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trafficking and localization

Abstract

In human, loss of Acid Sphingomeylinase (ASM/SMPD1) causes Niemann-Pick Disease, type A.
ASM hydrolyzes sphingomyelins to produce ceramides but protein targets of ASM remain largely
unclear. Our mass-spectrometry-based proteomic analyses have identified >100 proteins associated
with the ASM-dependent, detergent-resistant membrane microdomains (lipid rafts), with >60% of
these proteins being palmitoylated, including SNAP23, Src-family kinases Yes and Lyn, and Ras
and Rab family small GTPases. Inactivation of ASM abolished the presence of these proteins in
the plasma membrane, with many of them trapped in the Golgi. While palmitoylation inhibitors
and palmitoylation mutants phenocopied the effects of ASM inactivation, we demonstrated that
ASM is required for the transport of palmitoylated proteins, such as SNAP23 and Lyn, from the
Golgi to the plasma membrane without affecting palmitoylation directly. Importantly, ASM
delivered extracellularly can regulate the trafficking of SNAP23 from the Golgi to the plasma
membrane. Our studies suggest that ASM, acting at the plasma membrane to produce ceramides,
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regulates the localization and trafficking of the palmitoylated proteins.
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Introduction
The plasma membrane is a lipid bilayer composed primarily of phospholipids, as well as
sphingomyelins, cholesterol, glycol-sphingolipids and other less abundant lipid molecules such as
ceramides (Holthuis and Menon, 2014). Sphingomyelins comprise about 10-20% total lipids and
are asymmetrically localized in the outer leaflet of the lipid bilayer of the plasma membrane
(Holthuis and Menon, 2014). Sphingomyelins can also interact with cholesterol through their acyl
tails. The tightly packing of sphingomyelins and cholesterol can form an ordered lipid
microdomain, the lipid raft (Simons and Ikonen, 1997). Increasing evidence suggests that lipid
rafts can serve as signaling platforms to facilitate protein-protein interactions, as demonstrated for
the activation of T cell receptor (Lingwood and Simons, 2010; Rajendran and Simons, 2005).
Sphingomyelins can be converted to ceramides through the action of sphingomyelinases.
Ceramides, composed of a sphingosine and a fatty acid, are much more hydrophobic than
sphingomyelin. Ceramides can self-associate to form unique lipid microdomains in artificial
membrane or in the plasma membrane of erythrocytes (Holopainen et al., 1998; Lopez-Montero et
al., 2010; van Blitterswijk et al., 2003).

ASM (Acid Sphingomeylinase) catalyzes the hydrolysis of sphingomyelins to produce ceramides
and phosphocholine (Jenkins et al., 2009; Schuchman, 2007). In humans, loss-of-function
mutations in the ASM gene (also called SMPD1) cause the familial Niemann-Pick Disease, type A,
with severe neurological deterioration and lysosomal accumulation of excessive sphingomyelins in
brain, liver, spleen and lung cells, leading to the death of affected individuals at 1 or 2 years of age
(Schuchman, 2007). Biochemically, ASM acts as an sphingomyelinase that catalyzes the

sphingomylin are first synthesized from ceramides in the endoplasmic reticulum (ER), transported
to the Golgi Apparatus, and converted to sphingomyelin by sphingomyelin synthase 1 and 2
(SMS1 and 2) (Huitema et al., 2004). Sphingomylin is then transported to the outer leaflet of the
plasma lipid bilayer membrane. ASM, containing a saposin-like domain that is likely involved in
binding to sphingomyelins (Jenkins et al., 2009), is also exported, likely from lysosomes, to the
outer leaflet of plasma membrane to hydrolyze sphingomyelin into ceremides, which can form the
ceremide-enriched lipid rafts in response to stress stimuli (Cremesti et al., 2001; Grassme et al.,
2003; Lopez-Montero et al., 2010; Tam et al., 2010; van Blitterswijk et al., 2003). Under normal
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hydrolysis of sphingomyelin to produce ceremides and phosphorylcholine. The precursors of

conditions, the ratio of ceramides to sphingomeylins on the plasma membrane is usually low (15%) (Lopez-Montero et al., 2010; van Blitterswijk et al., 2003). However, in the ASM knockout
mice, many pathological defects of Niemann-Pick Type A diseases were reproduced, including the
extensive accumulation of sphingomyelin in liver, spleen, lung and brain cells (Horinouchi et al.,
1995; Otterbach and Stoffel, 1995). These genetic studies demonstrate that ASM is a dynamic and
critical regulator of sphingomyelin homeostasis in the plasma membrane. However, the
physiological function of ASM and the critical protein targets regulated by ASM remain unclear.

Palmitoylation is a post-translational modification of proteins that involves the covalent attachment
of saturated fatty acids, predominantly the C16:0 palmitate, to cysteine residues via a thioester
linkage (Charollais and Van Der Goot, 2009; Resh, 2013; Salaun et al., 2010). Palmitoylation
tethers the otherwise cytosolic proteins to the inner leaflets of the plasma membrane to facilitate
the lateral diffusion of proteins in the plasma membrane and to promote protein-protein interaction,
and is critical for signal transduction, synaptic function, membrane trafficking, and vesicle fusion
(Bijlmakers and Marsh, 2003; Smotrys and Linder, 2004). Many proteins, including the Src family
tyrosine kinases such as Yes and Lyn, membrane trafficking proteins such as SNARE (soluble
NSF attachment protein receptor) proteins, Ras family of small GTPases, receptors and channel
proteins, are modified by palmitate to regulate their membrane-associated activities. Although
palmitoylated proteins have been reported to be associated with lipid rafts in a manner requires
cholesterol participation (Chakrabandhu et al., 2007; Levental et al., 2010; Melkonian et al., 1999),
the roles of ceramides in such association remain undetermined.

worm homolog of ASM, asm-3, as a positive and novel regulator of the evolutionarily conserved
IGF-1 receptor (IGF-1R)-like signaling pathway (Kim and Sun, 2007; Kim and Sun, 2012). Our
recent studies in mammalian cells have shown that human ASM indeed functions to regulate the
receptor tyrosine kinase signaling pathways such as the Met tyrosine kinase signaling (Zhu et al.,
2016). In this report, we have used semi-quantitative proteomic approaches to identify proteins
associated with lipid rafts that are regulated by ASM in human cells. Our studies have revealed
novel function of ASM in regulation of intracellular protein localization and trafficking.
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We have recently conducted a functional genome-wide screen in C. elegans and identified the

Results

Using a biochemical procedure to fractionate ASM-regulated membrane-associated proteins

It has been shown that activation of CD95 death receptor in lymphoid cells is accompanied by the
CD95 receptor localization into the ceramide-rich lipid rafts, and such localization is ASMdependent, leading to CD95 receptor oligomerization, signaling and apoptosis (Cremesti et al.,
2001; Lopez-Montero et al., 2010; van Blitterswijk et al., 2003). However, our recent genetic
studies have shown that the C. elegans homolog of ASM is a positive regulator of the conserved
IGF-1R-like signaling pathway in vivo (Kim and Sun, 2007; Kim and Sun, 2012). We wondered if
ASM might regulate the localization of proteins in the ceramide-rich lipid rafts, and these proteins
might be positively involved in receptor tyrosine kinase signaling under physiological conditions.
To identify such proteins, we took a biochemical approach to isolate lipid rafts and analyze the
associated proteins by mass-spectrometry. By comparing the lipid raft proteomes identified in cells
with ASM or without ASM, we aim to identify the lipid raft-associated proteins that are regulated
by ASM.

The sphingomyelin-enriched lipid microdomains are known to be relatively resistant to nonionic
detergents, such as Triton X-100, and can be isolated as “the detergent-resistant membrane (DRM)
fractions”, which can be separated from the detergent-soluble fractions using a sucrose gradient
and ultracentrifugation (Harder et al., 1998; Schuck et al., 2003). Since lipid microdomains are
heterogeneous with varying lipid composition and protein content, their resistances to various

al., 2003). The detergent Brij has been shown to preserve the lipid raft localization of
transmembrane receptors (e.g., T cell receptor) better than Triton X-100 (Giurisato et al., 2003;
Montixi et al., 1998; Roper et al., 2000). Human IGF-1R can also be fractionated in the detergent
Brij-resistant membrane (DRM) fractions (Remacle-Bonnet et al., 2005). Since our genetic studies
have established that the worm homolog of ASM regulates the IGF-1R-like signaling pathway in
C. elegans (Kim and Sun, 2012), it is likely that human IGF-1R is also regulated by ASM. Indeed,
in human glioblastoma U373-MG cells, which are highly sensitive to ASM inhibition (Zhu et al.,
2016), we found there is a small fraction of IGF-1R localized in the Brij-resistant membrane
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detergents are known to be different (Giurisato et al., 2003; Radeva and Sharom, 2004; Schuck et

(DRM) fractions (fraction #1-4). However, most of the IGF-1R protein was localized in the Brijsoluble fractions (fractions #13-16) (Fig. 1A and 1B). We also found that the detergent Brij58,
rather than Triton X-100, was more efficient in preserving the lipid raft localization of IGF-1R
(data not shown). In cells treated with desipramine, the localization of IGF-1R in the DRM
fractions was reduced (Fig. 1B). Desipramine is a tricyclic amine anti-depression drug that acts as
a functional inhibitor of ASM, and the drug blocks the interaction of ASM with membrane inside
the lysosomes and causes ASM degradation (Albouz et al., 1981; Jaffrezou et al., 1995; Jenkins et
al., 2011; Zhu et al., 2016). Indeed, the ASM activity was potently suppressed in cells treated with
desipramine, confirmed by assaying the ASM activities using

14

C-sphingomyelin as a substrate

(Fig. 1E).

As control, we have found that Yes, a member of the src-family kinases known to be associated
with lipid rafts (Radeva and Sharom, 2004; Schuck et al., 2003), is also localized in the Brij-DRM
fractions (Fig. 1B). As the DRM fractions only contain 1% of total proteins (based on
quantification of protein concentrations using the Bradford assay), our studies revealed that Yes is
enriched in the DRM fractions. In cells treated with desipramine, there was a significantly reduced
level of the Yes protein in the DRM fractions, while the protein level of Yes in the soluble
fractions was slightly increased (Fig. 1B). In addition, we also found that a fraction of flotillin, a
known lipid raft protein, also associated with the Brij58-resistant lipid membrane fractions and this
membrane-associated fraction is also reduced after desipramine treatment (Fig. 1B). To confirm
these results, we also used two different ASM siRNAs to verify the reduced levels of Yes protein
in the DRM fractions in the ASM-inactivated cells (Fig. 1C and 1G). The Yes protein distribution

experiments, the efficiency of ASM siRNAs on ASM gene silencing was confirmed by assaying
the ASM activities using 14C-sphingomyelin as a substrate (Fig. 1E). The effects on ASM protein
levels by ASM siRNAs were also confirmed by immunoprecipitation/Western blot analysis, since
ASM protein was too low in abundance to be detected by straight Western blot analysis (Fig. 1F).

As cholesterol is reported to be involved in the formation of sphingomyelin-enriched lipid rafts, we
also tested the effects of cholesterol depletion on membrane proteins. Methyl-β-cyclodextrin
(MβCD) is a specific chemical that removes cholesterol from cultured cells. Previous reports
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in the pooled DRM fractions and pooled soluble fraction were also examined (Fig. 1G). In these

showed that depletion of cellular cholesterol by MβCD is accompanied with the loss of
sphingomyelin-enriched membrane rafts (Klein et al., 1995). We found that MβCD treatment also
caused the reduction of Yes from the DRM fractions (Fig. 1D), suggesting that Yes is associated
with lipid membranes that are sensitive to ASM and cholesterol depletion.

Mass-spectrometry analysis of ASM-dependent membrane-associated proteins
Having established a biochemical fractionation method to fractionate ASM-sensitive DRM
proteins, we took a proteomic approach to interrogate the DRM-associated proteins that are
potentially regulated by ASM (Fig. 2A). Briefly, U373-MG cells, treated with control or ASM
specific siRNAs, were lysed in the Brij58-containing buffer and fractionated by ultracentrifugation
on a sucrose gradient. The (DRM) fractions (fractions #1 to #4) were pooled, resolved on SDS
protein gel, followed by protein identification using an ESI-LTQ-Orbitrap XL mass-spectrometer
(Thermo Electron). Proteomic profiling data were first analyzed by QualBrowser in Xcalibur and
Proteome Discoverer and then by the Scaffold software to identify proteins with unique peptides
(described in details in the Materials and Methods). The obtained data were then subjected to the
label-free spectrum counting analysis, which has been used successfully to obtain a semiquantitative difference of protein abundance in two sets of the samples (Liu et al., 2004; Old et al.,
2005). Among 868 total protein hits analyzed, we have identified 108 DRM-associated proteins
that show a greater than 2-fold reduction in the cells treated with ASM siRNAs (siASM), as
compared with control cells treated with a non-specific luciferase siRNA (siLuc). These 108
proteins consituted a high confidence group, each identified by at least two unique peptides, in the
ASM-sensitive DRM-associated proteome (Suppl Table 1). The next group are 64 proteins, each

64 proteins constitutes the low confidence group (Suppl Table 1). However, not all proteins
identified have a reduced DRM association when ASM is knockdown. In fact, there are 116 of
proteins that show a greater than 2-fold increase with the DRM association when ASM is
inactivated, including a few members in the integrin family (Suppl Table 2). These observations
suggest that there present a set of proteins which association with DRM requires the function of
ASM.
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identified by at least one unique peptide, that show a change of abundance of >1.8-fold, and these

Enrichment of palmitoylated proteins in the ASM sensitive membrane fractions
When examining the list of proteins obtained by mass-spectrometry analyses (Suppl Table 1), we
noticed that the majority of the identified DRM proteins that are senstive to the loss of ASM are
peripherally membrane-associated proteins, whereas transmembrane proteins represent a relatively
small group. This could be due to a poor recovery of the transmembrane proteins by the isolation
procedure or due to the low abundance of the transmembrane proteins present in the DRM
fractions. We focused on characterizing the peripherally membrane-associated proteins to
investigate how these proteins might be associated with the ceramide-rich lipid rafts, as
inactivation of ASM should reduce the levels of ceramides in the membrane. We wondered
whether these proteins contain any common structural elements that help confer their membrane
lipid association properties.

During these mass-spectrometry-based proteomic analyses, we again recovered Yes as one of the
ASM-sensitive DRM proteins (Fig. 2B and 2D). Yes is known to be tethered to the cytosolic face
(the inner leaflet) of plasma membrane by palmitoylation (Resh, 1994; Sandilands et al., 2007).
Since palmitoylation is the most common acylation event in eukaryotes that allows otherwise
cytosolic proteins to be attached to the plasma membrane, we wondered if our ASM-sensitive
proteome has a selective enrichment of proteins that are palmitoylated. We therefore closely
examined whether there are additional palmitoylated proteins in our top list of the protein hits
through database search of reported literature and also by cross-referencing the protein
palmitoylation status in a palmitoyl-proteome database, the SwissPalm (Blanc et al., 2015). Indeed,

that 60% of these proteins (65 out of 108 proteins) are known to be palmitoylated (Suppl Table 3),
according to the previous studies by palmitoyl-proteomics analyses and other studies (Kang et al.,
2008; Rocks et al., 2010; Serwa et al., 2015). These 65 proteins can be categoried into cell surface
receptors (14%), SFKs and Ras-family GTPases involved in cell signaling (13%), proteins
participated in vesicular trafficking (31%), cytoskeleton reorganization (6%), scaffold proteins
(11%), metabolism (13%), and other functions (12%) (Fig. 2C). Some examples of the
palmitoylated proteins discovered in our ASM-sensitive DRM proteome are listed in Fig. 2B.
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among 108 proteins in our high-confidence group of the ASM-sensitive proteome, we have found

To verify the results from the mass-spectrometry-based proteomic analyses, we have examined
several representative proteins by independent Western blot analysis. Our analysis revealed that
similar to Yes, the levels of SNAP23 (the synaptosome-associated protein of 23 kDa), G(i)2
(GNAI2, heterotrimeric G protein subunit) and Rab-family of GTPases Rab7, were reduced in the
DRM fractions after cells were treated with ASM siRNAs (Fig. 2D). The membrane association of
these proteins was also sensitive to ASM inhibitor desipramine (Fig. 2D). These studies indicate
that our semi-quantitative mass-spectrometry analysis provides an effective way to identify the
ASM-sensitive, DRM-associated proteins.

The ASM-sensitive and DRM-localized proteins are palmitoylated proteins
Our proteomic approach has identified proteins such as SNAP23, Yes and G(i)2 that were
previously reported to be palmitoylated in other cells under various conditions. However, since
palmitoylation is a dynamic post-translational process, we would like to ensure that these proteins
are palmitoylated under our culture conditions in U373-MG cells. We therefore have used the
Acyl-Biotinyl Exchange (ABE) assay to examine the palmitoylation status of various proteins we
have identified (Fig. 2B and 2E). In the ABE assay (Kang et al., 2008; Roth et al., 2006),
sequential chemical modifications were used to selectively labeling the palmitoylated proteins by
biotin-HPDP, a sulfhydryl-reactive biotinylation reagent. The biotin-HPDP labeled proteins
(palmitoylated proteins) can be pulled down by the streptavidin-agarose resins. Using this specific
assay, we found that Yes, Lyn, Fyn, Ras, G(i)2, CD59, SNAP23, Rab7, and Rab14, which were
identified in our ASM-sensitive, DRM proteome (Fig. 2B), were all palmitoylated proteins in
U373-MG cells (Fig. 2E). Therefore, our proteome analysis selectively identified a large number

U373-MG cells.

Loss of ASM diminishes the plasma membrane distribution of palmitoylated proteins
Recent studies show that the Golgi apparatus is a major organelle to carry out the palmitoylation of
proteins, e.g. H-Ras and Fyn, which undergo dynamic cycling between the Golgi and plasma
membrane (Rocks et al., 2010; Rocks et al., 2005). These proteins are found to be palmitoylated on
the Golgi, trafficked to the plasma membrane, and then rapidly depalmitoylated and returned to the
Golgi, with a cycling time of about 20-30 minutes. We wondered whether ASM is involved in the
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of endogenous palmitoylated proteins that are enriched in ASM-regulated, DRM fractions in

regulation of the rapid subcellular cycling of the palmitoylated proteins. We therefore examined
the cellular localization of a group of palmitoylated proteins, including SNAP23, Yes, and G(i)2,
by immunostaining. Our examination revealed that these endogenous proteins all showed a
prominent localization in the plasma membrane in the control U373-MG cells (Fig. 3A and 3B,
indicated by arrows). However, we found that knockdown of ASM by two independent siRNAs or
treatment with desipramine, each greatly abolished the plasma membrane localization of these
proteins (Fig. 3A and 3B). Our quantification of these analyses indicated that inactivation of ASM
greatly diminished the plasma membrane distribution of these proteins (Fig. 3C and 3D). We also
further examined the effects of ASM inactivation on other palmitoylated proteins such as Lyn and
CD59. Our studies revealed that while both Lyn and CD59 are present on plasma membrane in
control cells, siRNA-mediated knockdown of ASM led to the disappearance of these proteins from
the plasma membrane (Fig. 3E). Our cell-based distribution studies, together with our mass
spectrometry-based proteomic profiling, indicate that the palmitoylated proteins are enriched in
ASM-sensitive DRM fractions and that ASM is required for the localization of these palmitoylated
proteins to the plasma membrane.

ASM deficiency causes the accumulation of SNAP23 in the TGN
We have noticed that while loss of ASM causes the disappearance of these proteins on the plasma
membrane, some proteins, such as SNAP23, started to accumulate in the intracellular perinuclear
region (Fig. 3A and 3B). SNAP23 is a SNARE protein that is ubiquitously expressed in a variety
of cells and is involved in a wide array of diverse vesicle membrane-membrane fusion events
including exocytosis from mast cells, insulin-dependent release of GLUT4 from adipocytes, and

centrally localized five cysteine residues that are shown to be linked to palmitoyl chains (Salaun et
al., 2005) and our studies showed that SNAP23 is indeed palmitoylated in U373-MG cells (Fig.
2E). To determine in which cellular compartment that SNAP23 may be trapped by the ASM
deficiency in U373-MG cells, we conducted co-immunostaining experiments. Our examination
revealed that siRNA-mediated knockdown of ASM caused the accumulation of SNAP23 in the
TGN region, colocalized with the TGN marker TGN46, but not with the cis-Golgi marker GM130
(Fig. 4A and 4B). We also examined the possibility that ASM inactivation may block the newly
synthesized SNAP23 to be trafficked to the plasma membrane through the TGN (Fig. 4C).
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neuronal postsynaptic glutamate receptor trafficking (Prescott et al., 2009). SNAP23 contains a

However, treatment of cells with protein synthesis inhibitor, cycloheximide, did not block the
presence of SNAP23 on the plasma membrane (Fig. 4C), suggesting SNAP23 is being recycled
through the TGN to appear onto the plasma membrane. Our results indicate that ASM inactivation
caused a failure of transport of SNAP23 out of the TGN.

Inhibition of palmitoylation prevents the plasma membrane localization of SNAP23
Since our studies indicate that ASM is required for the distribution of palmitoylated proteins such
as SNAP23 to the plasma membrane (Fig. 3 and 4), we tried to determine whether palmitoylation
is indeed required for SNAP23 to appear on the plasma membrane in our system. We used two
types of palmitoylation inhibitors, 2-bromopalmitate (2-BP) or cerulenin (Cr) (Resh, 2006), to
block the palmitoylation of SNAP23 and examined the changes of SNAP23 localization on the
plasma membrane. Our studies showed that treatment of cells with 2-bromopalmitate or cerulenin
greatly reduced the plasma membrane-associated SNAP23 (Fig. 5A). Using the Acyl-Biotinyl
Exchange assay, we found that the levels of palmitoylated SNAP23 proteins were significantly
inhibited by these palmitoylation inhibitors (Fig. 5B). Similarly, these palmitoylation inhibitors
also markedly diminished the palmitoylation levels of Yes (Fig. 5B). These studies again
confirmed that SNAP23 is indeed palmitoylated in our cells, and the palmitoylation status affects
SNAP23 intracellular localization. Notably, our studies revealed that SNAP23 staining on the
plasma membrane disappeared after the treatment of these palmitoylation inhibitors with
concurrent accumulation in the TGN region that overlapped with the TGN46 marker (Fig. 5A),
indicating that SNAP23 is palmitoylated in the TGN and its trafficking out of the TGN requires a
prior palmitoylation of the protein. Although there is a study suggesting that the palmitoylation of

report showing that the SNAP23 palmitoylation occurs on Golgi (Salaun et al., 2005). Since
palmitoylation inhibitors phenocopied the effects of ASM inactivation (comparing Fig. 4A and 5A)
on the dynamic distribution of SNAP23 from the plasma membrane to the TGN, our studies
strongly suggest that ASM regulates the palmitoylation-dependent vesicle transport of SNAP23
from the TGN to the plasma membrane.
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SNAP23 occurs on the plasma membrane (Weber et al., 2017), our data are consistent with the

ASM does not affect protein palmitoylation process itself
Since treatment of cells with palmitoylation inhibitors phenocopied the effects of ASM
inactivation on the distribution of SNAP23 on the plasma membrane and the TGN (Fig. 5A), it
remains unclear whether loss of ASM affects the palmitoylation process itself. To determine
whether ASM acts at the palmitoylation step or after palmitoylation of SNAP23, we directly tested
whether loss of ASM affects palmitoylation of SNAP23 or other proteins using the Acyl-Biotinyl
Exchange assay. We found that while treatment of cells with 2-bromopalmitate greatly inhibited
the palmitoylation of SNAP23 and Yes, however, knocking down of ASM did not affect the
palmitoylation levels of these proteins (Fig. 5B). Our studies thus indicate that ASM is not
required for the palmitoylation reaction of SNAP23 or other proteins per se. Rather, ASM
inactivation is likely to affect the association of SNAP23 and other palmitoylated proteins with
certain membrane components in the TGN, causing the failure of these proteins to be transported
out of the TGN.

Palmitoylation mutants fail to partition in the ASM-regulated membrane fractions
SNAP23 contains a centrally localized cluster of five cysteine residues, C79, C80, C83, C85, and
C87 that are known be palmitoylated (Salaun et al., 2005). These five cysteine residues are also
predicted to be palmitoylated according to the SwissPalm database analysis (Blanc et al., 2015). To
further characterize the role of palmitoylation in SNAP23 in association with the ASM-sensitive
DRM fractions, we have converted these cysteine residues to serine residues (C79S, C80S, C83S,
C85S, and C87S), and the C->S mutant derivative should not be palmitoylated. We also mutated

residue is known to be palmitoylated (Kovarova et al., 2001), and both cysteine 3 and 381 are
predicted to be palmitoylated according to the SwissPalm database analysis (Blanc et al., 2015). To
determine the role of palmitoylation in regulation of DRM association, we examined and
compared the behavioral differences of the Cys->Ser mutants of SNAP23 and Lyn to their wildtype counterparts after ectopically expressing them in cells. To distinguish the ectopically
expressed proteins from the endogenous ones, we have expressed the ectopically expressed
proteins as GFP fusion proteins, with GFP tagged at the N-terminus of SNAP23 and the Cterminus of Lyn, respectively (Fig. 6A and 6B). Expression of these proteins in U373-MG cells
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the cysteine residues at position 3 and 381 in Lyn to serines (C3S, C381S), since the cysteine 3

revealed that the Cys->Ser mutations in SNAP23 and Lyn greatly reduced their respective
palmitoylation levels based on the Acyl-Biotinyl Exchange assay, as compared to their wild-type
counterparts (Fig. 6A). In addition, while the exogenous GFP-SNAP23(CS) or GFP-Lyn(CS)
mutant proteins failed to be palmitoylated, the palmitoylation of the endogenous SNAP23 and Lyn
proteins are not affected, serving as a positive control for each cell line (Fig. 6A). In addition, we
found that these palmitoylation defective mutants of SNAP23 and Lyn also failed to associate with
the DRM fractions as analyzed by the discontinuous sucrose gradient ultracentrifugation method
(Fig. 6B). In comparison, the distribution of the endogenous SNAP23 in these DRM fractions was
sensitive to the ASM inhibitor desipramine (Fig. 6C), in a manner similar to the behavior of Yes
(Fig. 1B). These studies showed that the palmitoylation of SNAP23 and Lyn is required for their
association with the ASM-regulated DRM compartments. By fluorescence microscopy, our studies
revealed that while the wild-type GFP-SNAP23 and GFP-Lyn proteins were both found on the
plasma membrane, their palmitoylation-defective mutants failed to appear on the plasma
membrane (Fig. 6D). In fact, we found that these mutant proteins accumulated intracellularly,
likely in the Golgi area (Fig. 6D). Here again, our studies indicate that the behavior of these
palmitoylation-defective mutants of SNAP23 and Lyn phenocopied that of their endogenous
proteins in response to the ASM inactivation (Fig. 4 and 6). Thus, our studies provide strong
evidence that palmitoylation of these proteins is responsible for their association with the ASMsensitive DRM fractions, which correlates with their ability to be localized on the plasma
membrane, likely through trafficking out of the TGN.

Both ASM and ceramides are present on the cell surface

access to its substrates, sphingomyelins, which are asymmetrically localized on the outer-leaflet of
the plasma membrane (Lopez-Montero et al., 2010; van Blitterswijk et al., 2003). We used specific
anti-ASM antibodies to examine the cellular location of ASM. Our studies revealed that the ASM
protein is indeed found on the plasma membrane (Fig. 7A). The immunostaining of ASM on the
plasma membrane was specific since these stainings were abolished in cells treated with ASM
siRNAs or ASM inhibitor desipramine (Fig. 7A). Earlier studies have shown that when cells are
exposed to various lethal doses of stress stimuli, the ASM protein is translocated from intracellular
store(s) to the outer leaflet of the plasma membrane (Cremesti et al., 2001; Grassme et al., 2003;

Downloaded from http://bio.biologists.org/ at University of Nevada - Las Vegas on September 17, 2019

Biology Open • Accepted manuscript

We wondered if ASM might be localized on the plasma membrane, a location to allow an easy

Tam et al., 2010). Our data, however, indicate that ASM is normally present on the plasma
membrane in actively growing U373-MG cells even without the presence of stress stimuli. To
further determine that ASM protein is present on the plasma membrane, we immunostained live
cells directly using anti-ASM antibody without prior fixation. Indeed, plasma membrane ASM
staining was present in the control cells but not in the cells pretreated with ASM siRNAs (Fig. 7C).
Under this staining condition, there are some staining in the perinuclear regions in both control
cells and cells treated with ASM siRNAs, which might have occurred due to the antibodies being
endocytosed during the live staining process (Fig. 7C).

We also used a specific monoclonal anti-ceramide antibody to determine whether ceramides, the
products from the action of ASM on sphingomyelins, are found on the plasma membrane. Our
immunostaining of ceramides revealed that ceramides are indeed present on the plasma membrane
and such ceramide-immunostaining on the cell membrane surface was abolished in cells treated
with either ASM siRNAs or ASM inhibitor desipramine (Fig. 7A). The effects of ASM on the
plasma membrane lipids were selective, as we did not observe significant staining changes of GM1,
a member of gangliosides, on the plasma membrane in cells treated with ASM siRNAs or ASM
inhibitor desipramine (Fig. 7B). Our detection of ceramides in the plasma membrane is consistent
with earlier reports that ceramides are detected as a patch region on the plasma membrane,
although those ceramide-stained areas were only found on cells when challenged with strong stress
stimuli (Cremesti et al., 2001; Grassme et al., 2003; Tam et al., 2010).

Rescuing the ASM siRNA-mediated trafficking block of SNAP23 by the extracellular ASM

Since ASM and ceramides are detected on the plasma membrane (Fig. 7A-7C), we wondered
whether the extracellularly localized ASM could indeed act through ceramides on the plasma
membrane to regulate the intracellular trafficking of palmitoylated proteins from the Golgi to the
plasma membrane. To test this possibility, we performed a “rescue” experiment to determine
whether an exogenously supplied recombinant ASM enzyme can rescue the SNAP23 trafficking
defect in the ASM-deficient cells. For this experiment, we first silenced the ASM gene expression
by specific ASM siRNAs for 48 hours, and then incubated these ASM-deficient cells with the
active recombinant human ASM protein (rASM), or left untreated (control). As shown in Fig. 7D,
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treatment of cells with ASM siRNAs, but not the control siRNAs, caused the disappearance of the
plasma membrane staining of SNAP23. However, externally addition of the recombinant ASM
protein to the ASM siRNA-treated cells was sufficient to allow the re-appearance of SNAP23 on
the plasma membrane (Fig. 7D, and quantification in 7E). These results demonstrate that the
presence of ASM enzyme outside of the cell is able to reverse the phenotypes of trapping SNAP23
in the TGN in the ASM-deficient cells, allowing SNAP23 to exit the TGN and then to traffic to the
plasma membrane. These experiments suggest that ASM protein may function extracellularly to
produce ceramides by hydrolyzing sphingomyelin on the outer leaflet on the plasma membrane to
regulate the intracellular trafficking of the Golgi-localized palmitoylated proteins.

Discussion
In this report, we present our studies on using semi-quantitative mass-spectrometry analyses to
interrogate the proteins that are associated with the detergent (Brij58)-resistant membrane fractions
(DRMs). While more than 100 ASM-sensitive DRM-associated proteins were identified in the
actively growing U373-MG cells, our investigation revealed that a major fraction (60%) of these
proteins are palmitoylated proteins, including SFKs, Ras-family GTPases, Rab-family GTPases
and proteins involved in vesicular trafficking such as SNAP23 and syntaxins (Fig. 2B, Suppl.
Table 3). Our results indicate that ASM and its catalytic products, ceremides, are required for the
association of these palmitoylated proteins to the DRMs, both at the plasma membrane and at the
Golgi membranes or endosome membranes. Our characterization of the palmitoylation-defective
mutants of SNAP23 and Lyn suggests that the palmitoyl moiety in these proteins confers their

Our studies have also revealed a critical role of ASM in regulation of the trafficking of
palmitoylated proteins. We found that inactivation of ASM causes a number of proteins, including
SNAP23, Lyn, Yes, G(i)2 and CD59, to disappear on the plasma membrane, and concurrently
promotes the accumulation of these proteins intracellularly (Fig. 3). Using SNAP23 as an example,
we showed that ASM deficiency leads to SNAP23 accumulation at the Golgi, which can be
phenocopied by treating cells with palmitoylation inhibitors or by mutation of the palmitoylation
sites in SNAP23 (Fig. 4-6). Similar effect was observed with Lyn (Fig. 6). While it is possible that
ASM deficiency causes a defect in palmitoylation of SNAP23 and Lyn to account for their Golgi
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association to the ASM-sensitive DRMs.

transport defects, our subsequent characterization showed that ASM did not affect the
palmitoylation itself. Instead, ASM inactivation leads to a trafficking defect of these proteins to
exit out of the TGN after they are palmitoylated. Interestingly, we have recently found that ASM
deficiency blocked the trafficking of the MET receptor protein tyrosine kinase out of the Golgi to
the plasma membrane, while the transport of a viral protein VSVG was not affected by ASM
inactivation (Zhu et al., 2016). Therefore, it is possible that ASM is required for the selective
transport of certain cargos from specific subdomains in the Golgi. In fact, the lipid microdomains
of sphinomeylins and cholesterols have been proposed to act as a sorting platform on the Golgi to
help proteins transport (Schuck and Simons, 2004). Our studies have added one additional layer of
complexity to this model. It can be envisioned that ceramides on the Golgi membrane can provide
a favorable lipid microenvironment to allow the palmitoylated proteins to interact with the Golgi
transport machinery, although this case is to facilitate the transport carrier formation, rather than
sorting per se. It worth pointing out that our ASM-dependent DRM proteome analysis has
identified many ASM-regulated proteins that are involved in various processes of vesicular
transport, such as SNARE proteins and members of Rab GTPases. Future studies are required to
unravel the specific roles of ceramides in the regulation of Golgi transport.

Our studies have shown that ASM protein and ceramides are present on the plasma membrane in
the actively growing cells (Fig. 7). This is both consistent but different from the previous reports,
which showed that lethal doses of stress stimuli could stimulate the transport of ASM from the
intracellular stores, likely the luminal side of the lysosomes, to the extracytoplasmic side of the
plasma membrane (Cremesti et al., 2001; Grassme et al., 2003; Tam et al., 2010). Specifically, we

actively growing glioblastoma cells, even without exposure to stress stimuli. The presence of ASM
and ceramides on the plasma membrane of actively growing cells suggests that the enzyme and the
lipids have a normal function in cells, which is consistent with our genetic studies in C. elegans
demonstrating that the ASM homolog is required for the IGF-1R-like signaling pathway under
physiological conditions (Kim and Sun, 2012). Importantly, our rescue experiments revealed that
externally added ASM on the extracellular leaflet of the plasma membrane is sufficient to regulate
the intracellular Golgi transport of the palmitoylated proteins (Fig. 6C). We believe that ASM can
produce ceramides on the plasma membrane, which then communicate with the Golgi to regulate
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found that high levels of ASM proteins and ceramides are present on the plasma membrane in

the transporting of the palmitoylated proteins. It has been reported that synthetic ceramide analog,
C6-ceramide, can be taken up by the cells from culture medium to be transported back to the Golgi
(Martin and Pagano, 1994). In our model (shown in Fig. 7F), ASM acts at the outer-leaflet of the
plasma membrane to convert sphingomyelins to ceramides. While sphingomyelins are mainly on
the outer leaflet of the plasma membrane, ceramides can flip-flop and are therefore present on both
leaflets. In addition to the self-association property of ceramides, the removal of the
phosphorylcholine head group on the sphingomyelin could also make the otherwise deeply buried
cholesterol accessible. Ceramides can retrogradely traffic back to TGN. On the Golgi membrane,
ceramides recruit the palmitoylated proteins such as SNAP23 and Lyn to facilitate the transport of
these proteins out of the TGN. When ASM is inactivated, SNAP23 and Lyn are trapped in the
TGN, due to the lack of the ceramides on the Golgi membrane that are essential for the transport of
the palmitoylated proteins out of the TGN. Interestingly, as ASM itself can be found at the plasma
membrane in actively growing cells, a location that may allow ASM activity to be regulated by
extracellular growth factors, cell attachment and pH environment, which can in turn modulate the
function of plasma membrane or the Golgi to govern cell signaling and intracellular Golgi
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transport processes in a temporally and spatially controlled manner.
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Experimental Procedure:

Cells, antibodies, and reagents:
Human glioblastoma U373-MG cells were obtained from American Type Culture Collection
(ATCC) and were cultured in Dulbecco's Modified Eagle Medium (DMEM, Invitrogen)
supplemented with 10% fetal bovine serum, penicillin and streptomycin at 37ºC, 5% CO2.
Antibodies for ASM (H-181, sc-11352), Lyn (H-6, sc-7274), Flotillin-2 (clone B-6, sc-28320),
VAMP3 (N-12, sc-18208), and G(i)2 (L5, sc-13534) were purchased from Santa Cruz
Biotechnology; antibodies for SNAP23 (ab4114), Rab14 (ab40938) and GM1 (ab23943) were
from Abcam; antibodies for Rab7 (#9367) and Yes (#2734) were from Cell Signaling; antibodies
for TGN38 (#610898), GM130 (#610822), CD59 (clone p282, H19), Fyn (clone 25/Fyn) and
Fixation and Permeabilization Solution (#554722) were from BD Biosciences; antibodies for
ASM/SMPD1 (AF5348, goat IgG), ASM/SMPD1 (MAB5348, mouse IgG2A), and recombinant
human ASM/SMPD1 protein (#5348-PD) were from R&D Systems; anti-ceramide mouse
monoclonal antibody (clone MID15B4) was from Enzo Life Sciences; anti-Ras (clone 9A11.2,
recognizes H, N, K-Ras) mouse monoclonal antibody was from EMD Millipore. Alexa Fluor 488conjugated goat anti-mouse IgG, 488-conjugated anti-rabbit IgG, Alexa Fluor 647-conjugated antimouse IgG, Alexa Fluor 647-conjugated anti-rabbit IgG antibodies, ChromPure Rabbit IgG (011000-003), ChromPure Mouse IgG (015-000-003), ChromPure Goat IgG (005-000-003), and
normal goat serum (005-000-121) were from Jackson Immunologicals. Streptavidin-HRP was
from Pierce (Thermo), protein A and G Sepharoses were from GE Healthcare. DAPI (4', 6diamidino-2-phenylindole, 32670), desipramine hydrochloride (D3900), 2-bromopalmitate

from Sigma-Aldrich.

Small RNA (siRNA) interference and compound treatment
All siRNAs were synthesized by Dharmacon. Sequences of siRNAs: Human Luciferase siRNA: 5'CGTACGCGGAATACTTCGA-3', Human ASM siASM-1: 5'-CTACCTACATC
GGCCTTAA-3', siRNA-siASM-2: 5'-AGACCTACATCCTGAATCT-3'. U373-MG Cells were
transfected with 50 nM siRNAs using oligofectamine (Invitrogen) for 48-72 hours. For
immunostaining, cells were trysinized at 48hr after transfection and cultured on 24-well plate for
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(238422), cerulenin (C2389), cycloheximide, and methyl-β-cyclodextrin (MβCD, M7439) were

overnight growth.

For drug treatment, cells were typically treated with 10 mM Methyl-β-

cyclodextrin (MβCD) for 1 hour; 25 M desipramine for 4 hours or overnight, 100 M 2bromopalmitate for 6 hours, and 5 g/ml cerulenin for 6 hours. Immunfluorescence staining and
microscopy were conducted as described below. Immunoprecipitation and Western blotting were
conducted as described previously (Zhang et al., 2013).

cDNA Expression constructs
The cDNA encoding SNAP23 was synthesized and cloned into the pcDNA3.1-N-eGFP vector to
derive the pcDNA-N-GFP-SNAP23 construct (service provided by GenScript, Piscataway, NJ).
Cys->Ser mutations were subsequently introduced at the amino acid 79, 80, 83, 85 and 87 in the
SNAP23 cDNA. pEGFP-N1-human Lyn–GFP was a gift from Anna Huttenlocher (Addgene
plasmid # 35958) (Yoo et al., 2011). Cys->Ser mutations were subsequently introduced at the
amino acid 3 and 381 in the Lyn cDNA. Site-directed mutagenesis of SNAP23 and Lyn to
introduce Cys->Ser mutations were conducted by GenScript (Piscataway, NJ) and all cDNAs were
confirmed by sequencing. The expression plasmids were transfected to U373-MG cells by
Lipofectamine 2000 and the stable transfectants were obtained following selection for G418
resistance.

Sphingomyelinase assay
Sphingomyelinase assay was conducted according to described (Horinouchi et al., 1995; Otterbach
and Stoffel, 1995). Briefly, cells were lysed in a buffer containing 0.2% Triton X-100, 100 mM
sodium acetate, pH 5.2, 1mM EDTA and with protease inhibitor mixes (Sigma), and sonicated

4°C. Samples were normalized for protein concentration using the Bio-Rad protein assay. The
substrate, [Choline-Methyl-14C] sphingomyelin (0.02mCi/ml, NEC663010UC, PerkinElmer), was
dried and re-suspended in the assay buffer (250 mM sodium acetate, pH 5.2, 1mM EDTA, 0.2%
Triton X-100) and sonicated. Then 100 l of sphingomyelin substrate and 100 l of clarified cell
lysates were incubated at 37°C for 30-60 minutes with occasional vortexing. The enzyme reaction
was terminated by addition of 0.8 ml of CHCl3: MeOH (2:1, v/v) followed by 0.2 ml of water.
Samples were vortexed, centrifuged at 5,000Xg for 95 minutes, and 0.3 ml of upper aqueous phase
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briefly (10s, three times). Cell debris was pelleted by centrifugation at 13,000 rpm for 5 minutes at

was removed for liquid scintillation counting. The assay was linear with time and protein
concentration and the maximum substrate hydrolysis was less than 10%.

Isolation of Brij58-resistant membrane fractions
The Brij-resistant membrane and soluble fractions were isolated according to the described
procedure (Giurisato et al., 2003; Montixi et al., 1998; Roper et al., 2000). U373-MG cells grown
on the 100 mm tissue culture dishes were washed with ice-cold 1XPBS for 2 times and then
incubated with 250 l ice-cold MBS buffer (25 mM MES, pH6.5, 150 mM NaCl, 50 mM NaF, 2
mM sodium pyrophosphate, 1 mM sodium vanadate, 20 mM -glycerophosphate) containing 1%
Brij58 and the protease inhibitor mixes (10 g/ml aprotinin, 1mM benzamidine, and 10 g/ml
leupeptin). Cells were then scraped off the dish and homogenized with a Dounce homogenizer (1
ml) with 20 strokes. Two 100 mm dishes of cells were used for each sample. Cell debris was
clarified by centrifugation at 960xg for 10 minutes at 4 °C and the clarified cell extracts were
normalized for equal amount of total proteins in each sample in 500 l total volume. The lysates
were mixed with equal volume (500 l) of 80% sucrose in the MBS buffer (sucrose-MBS) with 1%
Brij58 to obtain 40% final sucrose concentration. This mixture was loaded under the 3.2 ml of 35%
sucrose-MBS in the centrifuge tube; and an additional 0.80 ml of 5% sucrose-MBS was added
slowly on top of 35% sucrose-MBS to form a discontinuous sucrose gradient of 5%, 35%, and 40%
for buoyant density gradient ultracentrifugation. The sucrose gradients were centrifuged in a
Beckman SW55 Ti swinging rotor at 41,000 rpm, 40C, for 18 hours. After centrifugation, 300 l
per fraction was taken from the top (low density, fraction #1) to the bottom (high density, fraction
#16) of the centrifuge tube. The Brij58-resistant membrane fractions were isolated as a band from

bottom fractions (fractions #13-#16). By Bradford protein concentration determination, total
protein concentration in pooled fractions of #1-#4 is only 1% of the total protein concentration in
the pooled fractions of #13-#16. Proteins associated with the fractions were analyzed by Western
blotting with specific antibodies or processed for mass spectrometry proteomic analysis.
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the 5% to 35% sucrose interference (fractions #1-#4), where Brij58-soluble fractions were in the

Protein gel electrophoresis and in-gel trypsin digestion
Fraction #1-4 from the ultracentrifugation were pooled, and concentrated by Amicon Ultra
centrifugal filters (10 kDa cut-off, Millipore) then resolved on a 4-12.5% gradient Nu-PAGE gel
(Invitrogen). Proteins were stained with Coomassie Blue, and extracted from the gel by first slicing
the gel to twenty-four equally spaced gel pieces from the bottom to the top of the gel (10-300 kDa).
Individual gel slices were destained with 25 mM NH4HCO3 in 50% acetonitrile (ACN), reduced
with 20 mM dithiothreitol in 25 mM NH4HCO3 for 1 hour at 37°C, and alkylated with 55 mM
iodoacetamide in 25 mM NH4HCO3 in the dark for 1 hour at room temperature. After washing, the
gel slices were dehydrated with ACN and dried using a Speed-Vacuum system. Mass
spectrometry-grade trypsin (Promega) was incubated with each gel slice overnight at 37℃. The
supernatant was collected and dried using a Speed-Vacuum for subsequent liquid chromatography
mass spectrometry (LC-MS/MS) analysis.

Mass spectrometry-based proteomic analysis of proteins
Tryptic peptides derived from each gel slice were analyzed by an on-line C18 nano-flow reversedphase liquid chromatography instrument (Easy nano-liquid chromatography) connected to an LTQ
Orbitrap XL mass spectrometer (Thermo Scientific). Samples were concentrated onto an in-house
packed 100-nm-inner diameter x 1-cm C18 column (Magic C18, 5 µm, 300 Å, Michrom
Bioresources Inc.) then separated on 50-nm-inner diameter x 15-cm C18 column at 300 nl/min
with 75min linear gradients from 0 to 35% acetonitrile in 0.1% formic acid. The LC eluent was

ionization voltage of 2.2 KV. During the chromatographic separation, the LTQ Orbitrap XL is
operated in a data-dependent mode and under the direct control of Xcalibur (Thermo). The mass
spectrometry (MS) data were acquired using the following parameters: 5 data-dependent collisioninduced dissociation MS2 scan survey in the linear ion trap per every full scan in the Orbitrap with
the resolution set to a value of 60,000; 35% normalized collision energy in CID; +/-2 Da isolation
window.
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directly nanosprayed into an LTQ Orbitrap XL mass spectrometer (Thermo Scientific) with an

Proteomic data analysis
Proteomic profiling data were first analyzed by QualBrowser in Xcalibur and Proteome Discoverer
to identify proteins with unique peptides, and followed by analysis with the Scaffold software
(Proteome Software, Oregan, Portland) which uses advanced algorithms to improve statistical
significance. Only proteins that passed the protein probability threshold above 99%, peptide
probability threshold above 95%, and contained at least 1 unique peptide were taken for label-free
quantitation. Total number of high quality peptides identified in the DMSO control or
desipramine-treated samples are 3345 and 3644, respectively, which were then subjected to spectra
counting. The spectrum number from each experiment was exported to Excel spreadsheets and the
relative abundance of proteins were calculated based on the published protocols. Details are
described below.

The Thermo .raw files were analyzed by Proteome Discoverer (version 1.0) which searched
against IPI human database (v3.75; 89,486sequences) using following parameters: two tryptic
mass cleavages, 10 ppm precursor ion mass tolerance, 0.8Da fragment ion mass tolerance, fix
modification of carbamidomethyl on cysteines, and variable protein modification of oxidation on
methionines. For protein identification and label-free quantitation, the .msf files generated from
Proteome Discoverer were subsequently analyzed by Scaffold 3 software (version 3.0; Proteome
Software Inc., Portland Oregon).

5.0% with at least one unique peptide identification. The spectra counts were used to calculate the
relative abundance of proteins were calculated based on the published protocols(Liu et al., 2004;
Old et al., 2005): RSC =log2 [(n2 + f) / (n1 + f )] + log2[(t1 -n1 +f )/(t2 - n2 + f )], where, for each
protein, RSC is the log2 ratio of abundance between Samples 1 and 2; n1 and n2 are spectral counts
for the protein in Samples 1 and 2, respectively; t1 and t2 are total numbers of spectra over all
proteins in the two samples; and ƒ is a correction factor set to 1.25. The candidate ASM-dependent
membrane-associated proteins are defined as the proteins that were sensitive to ASM siRNA using
a threshold of 2.0 and at least two unique peptides, and this group of proteins is defined as the high

Downloaded from http://bio.biologists.org/ at University of Nevada - Las Vegas on September 17, 2019

Biology Open • Accepted manuscript

Results were filtered on Scaffold to achieve a protein probability < 1.0% and peptide probability <

confidence group. In addition, there are a group of proteins which contains at least one unique
peptide, with a change of protein abundance threshold of 1.8, and this group of proteins is
considered low confidence group.

Immunofluorescence microscope image acquisition
Cells were cultured on 24-well plate for 24 hours and then the cells were transfected with specific
ASM siRNAs or treated with specific chemical compound for indicated times. Cells were washed
briefly with PBS and immediately fixed with BD Fixation and Permeabilization Solution for 30
minutes. After incubated with the primary antibodies overnight at 4ºC, cells were washed in PBS
and incubated with fluorescence labeled secondary antibodies or with biotin-streptavidin system at
room temperature. Cells were staining with PBS containing 1μg/ml DAPI for DNA counter
staining. Images were captured by an automated confocal microscope system with high content
screen capability, OperaTM LX (Perkin Elmer Inc.) with 24x (NA1.0) or 40x (NA1.1) water
immersion lenses. Images were processed by using the onboard Acapella software. Alternatively,
images were acquired by Nikon A1R+ confocal microscope using 40X oil immersion lens (NA1.3),
as described (Zhu et al., 2016). Quantitations of the relative proteins abundance on the plasma
membrane are carried out using the fluorescence images and ImageJ software (Schindelin et al.,
2012), as described (Zhu et al., 2016). ChromPure Rabbit IgG or ChromPure Mouse IgG was used
as negative controls.

The Acyl-Biotinyl Exchange (ABE) Assay for palmitoylated proteins
1x108 active growing U373-MG cells were collected by centrifugation and then re-suspended in 3

stock prepared in ethanol), 2x protease inhibitor mix (Sigma) and 2 mM phenylmethylsulfonyl
fluoride (PMSF), and then homogenized with 25 strokes of a Dounce homogenizer. Triton X-100
was added to 1.7% and the lysate was incubated with gentle mixing for 1 hour at 4ºC. Cell debris
was removed by centrifugation at 5000 rpm for 10 minutes. The ABE assays were performed
according to (Kang et al., 2008; Roth et al., 2006). Briefly, proteins were precipitated by a
chloroform-methanol mixture and then treated extensively with N-ethylmaleimide (NEM) to block
free thiol groups. After reaction, free NEM was removed by sequential chloroform-methanol (CM)
precipitation. In the NEM-blocked lysates, the palmitoyl group of palmitoylated proteins is
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ml ice-cold lysis buffer containing 10 mM N-ethylmaleimide (NEM, freshly diluted from 1M

removed from the palmitoylated thio groups of cysteine residues by treating the lysates with or
without hydroxylamine (HA). The HA-exposed thio groups were labeled with biotin-HPDP and
the free biotin-HPDP is removed by precipitation. The precipitated proteins were solubilized and
the biotin-HPDP modified proteins were incubated with streptavidin-agarose resins. The bound
proteins on the streptavidin-agarose beads were extensively washed (>four times) with the lysis
buffer and then bound proteins were separated in SDS-PAGE. Specific proteins in the streptavidinagarose beads were identified by Western blotting with specific antibodies.

Statistical analysis:
Experiments were usually performed with at least three independent repeats (biological replicates)
to ensure the results. For cell number assays, triplicated repeats in the same set of cells were
measured and the experiments usually repeated in three independent experiments with different
cultured cells. Quantitative data are expressed by bar graph and standard deviations (S.D.) are
expressed as mean and error bars. For siRNA-mediated knockdown or drug treatment experiments,
statistically significant differences between means of control and knockdown/drug treated were
compared using a two-tailed equal-variance independent t-test(Fay and Gerow, 2013). Different
data sets were considered to be statistically significant when the P-value was <0.01.
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Figure 1. Fractionation of the ASM-regulated membrane-associated proteins by
discontinuous sucrose gradient ultracentrifugation.
A. A schematic workflow of the discontinuous sucrose gradient fractionation procedure.
B. The distribution of tyrosine kinases IGF-1R and Yes in the discontinuous sucrose gradient in
control (DMSO) and desipramine (Desi, 25 μM, 12 hours) treated U373-MG cells by anti-IGF-1R
and anti-Yes antibody immunoblotting. Flotillin was used as a lipid raft marker. Fractions were
collected from the top (fraction #1) to the bottom of the gradient (fraction #16). The distribution of
IGF-1R or Yes was reduced in the detergent resistant membrane (DRM) fractions (#1-#4) after
ASM inhibition.
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C. Loss of ASM reduced the levels of Yes in the detergent resistant membrane fraction. U373-MG
cells were transfected with 50 nM control (luciferase, siLuc) and ASM siRNAs (siASM) for 48
hours and the cells were harvested in the Brij58-containing lysis buffer and fractionated and
analyzed as in B.
D. The same as in B except U373-MG cells were treated control (PBS) or 10 mM MβCD for 1
hour and the cells were harvested in the Brij58-containing lysis buffer, fractionated, and analyzed
as in B.
E The reduction of ASM activities in the desipramine-treated cells or the ASM siRNAs-treated
cells were determined using the sphingomyelinase assay, as compared with control cells. Data are
means ± s.d. (n=3) with three independent repeats.
F. Knockdown efficiency of two independent ASM siRNAs on the ASM protein levels in U373MG cells. ASM was immunoprecipitated from the lysates and then analyzed by Western blot by an
anti-ASM antibodies.
G. Independent verification of the effects of ASM siRNAs, desipramine, and MβCD on the
distribution of Yes in discontinuous sucrose gradient. U373-MG cells were transfected with 50 nM
control (siLuc) and two independent ASM siRNAs for 48 hours or treated with 25 μM desipramine
for 10 hours or 10 mM MβCD for 1 hour. The cells were harvested in the Brij58-containing lysis
buffer and fractionated. The distribution of Yes was monitored in the pooled DRM fractions
(fraction #1-#4) or soluble fractions (fraction #13-#16) by Western blotting.
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Figure 2. Mass spectrometry-based proteomic analysis of ASM-regulated DRM-associated
proteins.
A. A schematic illustration of the proteomic procedure to analyze ASM-regulated DRM-associated
proteins.
B. A partial list of proteins identified the ASM-sensitive DRM proteome. Proteins identified are
cross-referenced to the palmitoyl-proteome database (SwissPalm) and 65 proteins are found to be
known palmitoylated proteins (Suppl Table 3). Selected proteins from the Supplmentary Table 3
are listed here. Semi-quantitative mass-spectrometry data, fold of protein abundance change
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between control siLuciferase and siASM, as well as numbers of peptides identified in each
condition, for the listed proteins are shown in the middle columns. The numbers of articles that
reported the particular protein found in the palmitoyl-proteome is indicated in the last column.
C. A pie illustration to indicate the functional categories and the percentage of proteins in each
category. Analysis is based on the identified palmitoylated proteins in the ASM-sensitive DRM
proteome (Supplmentary Table 3).
D. Validation of the mass-spectrometry-based quantitation by Western blot analysis. Selected
proteins from the list in panel B were subjected to Western blot analysis using corresponding
antibodies. Cells were treated with ASM siRNA or desipramine, or corresponding controls, and
subjected by discontinuous sucrose gradient ultracentrifugation analysis. The pooled DRM
fractions are analyzed as described in Fig. 1G.
E. The Acyl-Biotinyl Exchange (ABE) assay to detect protein palmitoylation. Lysates from U373MG cells were exposed to NEM to block all unmodified free thio groups (-SH) in the cysteine
residues. The NEM-treated cell lysates were next exposed to hydroxylamine (HA), or left
untreated. Both groups were then incubated with biotin-HPDP and subsequently pulled down by
the streptavidin-agarose resins, followed by Western blot analysis. Palmitoylated protein are
enriched by HA treatment as compared to the no prior HA treatment group. Whole cell lysates
(WCL) were used as control.
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Figure 3. ASM-deficiency reduces the plasma membrane localization of the palmitoylated
proteins.
A and B. Selective inactivation of ASM by two independent siRNA (A) or ASM inhibitor
desipramine (B) reduced the plasma
membrane localization of SNAP23, Gα(i)2, and Yes, as compared with cells treated with
corresponding controls. Cells were
processed by immunostaining with specific antibodies and examined by fluorescence microscopy.
The plasma membrane staining of specific proteins is indicated by arrows.
C and D. Quantification of cell imaging data from A and B. Inhibition of ASM leads to strong
reduction of SNAP23, Gα(i)2, and Yes on cell membranes. Relative plasma membrane staining
was obtained by quantitation of the intensity of the fluorescence staining on the plasma membrane
as compared with the intensity of the staining in the whole cells (200 cells were measured for each
condition), using ImageJ software. Experiments were repeated three times to derive the average
(the mean) of the relative abundance for the plasma membrane associated protein (statistical
significant, P<0.01, Student’s t-test).
E. Silencing ASM also reduces the plasma membrane staining of Lyn and CD59. Cells were
treated with two independent ASM siRNAs, and stained with antibodies for Lyn, or CD59,
respectively (green), and countered stained with DAPI, a DNA binding dye to stain the nucleus
(blue).
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Figure 4: Inactivation of ASM blocks the plasma membrane delivery of SNAP23 with
concurrent accumulation in trans-Golgi network (TGN).
A and B. U373-MG cells were transfected with 50 nM control (Luc) or two independent ASM
siRNAs for 48 hours. Cells were co-immunostained with anti-SNAP23 (red) and TGN marker
TGN46 (green) in panel A, or SNAP23 (red) and cis-Golgi marker GM130 (green) in panel B.
Inactivation of ASM leads SNAP23 to disappear from the plasma membrane (indicated by arrows)
and accumulated intracellularly (indicated by arrowheads) that are co-localized with TGN46
(yellow) but not with GM130. Inset: boxed regions are enlarged. Scale bars, 10 m.
C. U373-MG cells were treated with cycloheximide (50 μg/ml, CHX), or vehicle DMSO for 6
hours, and stained as in panel A.
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Figure 5. Palmitoylation regulates the plasma membrane delivery and membrane-association
of palmitoylated proteins.
A. Palmitoylation inhibitors block the appearance of SNAP23 on the plasma membrane and cause
SNAP23 accumulation in the TGN. U373-MG cells were treated with palmitoylation inhibitors 2bromopalmitate (2-BP, 100 µM) or cerulenin (Cr, 5 µg/ml) for 6 hours. Cells were coimmunostained for SNAP23 (red) and the TGN marker TGN46 (green), and counter-stained with
DAPI for nuclei (blue). Both drug treatment lead to a disappearance of SNAP23 on the plasma
membrane and the co-localization of SNAP23 with TGN46 (yellow), indicating trapping of
SNAP23 in the TGN.
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B. Inactivation of ASM does not affect protein palmitoylation. Palmitoylation of SNAP23 and Yes
was each greatly reduced after treatment of cells with 2-bromopalmitate (upper panels) but not
after ASM knockdown. U373-MG cells were treated with 100 µM 2-bromopalmitate (2-BP) for 6
hours or transfected with 50 nM control and ASM siRNAs for 48 hours. Palmitoylation of
SNAP23 and Yes were analyzed using the ABE assay, as in Fig. 2E.
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Figure 6. DRM-association and intracellular localization of the palmitoylation-defective
SNAP23 and Lyn.
A. Mutations of specific cysteines in SNAP23 and Lyn greatly reduced their palmitoylation. Wildtype (wt) and cysteine to serine (CS) mutants of SNAP23 and LYN were expressed as GFPSNAP23 and GFP-Lyn fusion proteins, with GFP tagged at the N-terminus of SNAP23 and Cterminus of Lyn, respectively. Expression constructs were stably transfected into U373-MG cells.
The cell lysates were prepared and palmitoylation of the wild-type and CS mutants were analyzed
using the ABE assay as in Fig. 2E. While the exogenous CS mutant of SNAP23 and Lyn have
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greatly reduced palmitoyltion levels, the palmitoylation status of the endogenous SNAP23 and Lyn
are not affected, further serving as controls.
B. Cysteine mutants of SNAP23 and Lyn failed to associate with the detergent Brij58-resistant
membrane fractions (DRMs). Wild-type (wt) and CS mutants of GFP-SNAP23 and GFP-Lyn
proteins were stably transfected into U373-MG cells, respectively. The cells were lysed in Brij58containing lysis buffer and fractionated in the discontinuous sucrose gradient ultracentrifugation,
as in Fig. 1B, and the pooled fractions were examined by Western blot analysis, as described in Fig.
1G. Only the wild-type but not the CS mutant proteins are found in the DRM fractions, while the
CS mutant proteins are found mostly in the pooled soluble fractions.
C. Association of SNAP23 with the detergent Brij58-resistant membrane fractions (DRMs) is
sensitive to the ASM inhibitor desipramine. U373-MG cells were treated with the ASM inhibitor
desipramine or vehicle control DMSO for 12 hours. Lysates were prepared in the Brij58 lysis
buffer, and subjected to the sucrose discontinuous sucrose gradient ultracentrifugation as described
in Fig. 1B. The fractions were analyzed by Western blot analysis using anti-SNAP23 antibodies.
D. CS mutants of GFP-SNAP23 and GFP-Lyn failed to appear on the plasma membrane and were
accumulated in the intracellular compartment. Wild-type (wt) and CS mutants of GFP-SNAP23
and GFP-Lyn constructs were transfected into U373-MG cells. The localization of the GFP-tagged
ectopically expressed proteins on the plasma membrane and intracellular compartment was
examined by fluorescence microscopy. Scale bars, 10 m.
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Figure 7. ASM acts at the plasma membrane to regulate the intracellular trafficking of
palmitoylated proteins.
A. U373-MG cells were treated with 50 nM control and two independent ASM siRNAs for 48
hours. Alternatively, cells were treated with 25 μM desipramine or DMSO for 12 hours. The
localization of ASM and its catalytic product, ceramide, was examined by specific anti-ASM
and anti-ceramide antibody immunostaining. The plasma membrane staining of both ASM and
ceramide (indicated by arrows) disappeared in cells after treatment with ASM siRNAs or with the
ASM inhibitor desipramine.
B. The distribution of ganglioside GM1 on the plasma membrane is not affected by ASM
inactivation. The experiments were conducted similarly as panel A except that cells were
immunostained with an anti-GM1 antibody (immunostaining of GM1 on the plasma membrane
is indicated by arrows).
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C. Cells were transfected with siRNAs as in panel A for 48 hours. Live cells were stained directly
with anti-ASM antibodies at room temperature for 1 hour. Cells were then fixed, and processed for
staining with by secondary antibodies and imaging.
D. Extracellular recombinant ASM enzyme can rescue the trafficking defects of SNAP23 in the
ASM siRNA-treated cells. U373-MG cells were transfected with 50 nM control and ASM siRNAs
for 48 hours. In one set of the ASM siRNA-treated cells (right panel), purified recombinant
active recombinant human ASM enzyme (4 μg/ml final) was added to the culture media for 2
hours. Cells were then fixed, processed by immunostaining with anti-SNAP23 antibody, and
examined by fluorescence microscopy.
E. For quantification, the relative abundance of SNAP23 under all three conditions in panel C was
measured (200 cells from each condition), as in Fig. 3C, and then normalized to control cells.
Three independent experiments were measured to obtain the average (the mean value)
of SNAP23 distribution on the plasma membrane (statistical significant, P<0.01, Student’s t-test).
F. A model for the ASM function in regulation of SNAP23 and Lyn trafficking. ASM acts at the
outer-leaflet of the plasma membrane (PM) to convert sphingomyelins (SM) to ceramides (CER).
While CER are found in both leaflets of the plasma membrane, SM are mainly on the outer leaflet
of the plasma membrane. Ceramides can retrogradely traffic back to Golgi (TGN).
On the Golgi membrane, ceramides recruit the palmitoylated proteins such as SNAP23 and Lyn to
facilitate the transport of these proteins out of the Golgi. SNAP23 and Lyn are carried by the
ceramide-rich transport vesicles (possibly endosomes) en route to the plasma membrane, which
eventually fused with the plasma membrane. On the plasma membrane, SNAP23 and Lyn
are also associated with ceramides-rich lipid microdomains. When SNAP23 and Lyn are
depalmitoylated, the depalmitoylated proteins become cytosolic, and then associate with Golgi to
be palmitoylated again, starting another cycle of trafficking. When ASM is inactivated, SNAP23
and Lyn are trapped in the Golgi, due to the lack of the ceramides on the Golgi membrane, which
are essential for the transport of the palmitoylated proteins out of the Golgi.
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Table S1. The spectral counting data for the protein hits that are decreased in the DRM
association following ASM siRNA treatment.
U373-MG cells were treated with the luciferase siRNAs (siLuc) as control or with ASM specific siRNAs
(siASM). DRM fractions from both samples were processed and analyzed by OrbiTrap mass-spectrometer.
Proteomic data were analyzed by Proteome Discoverer software and Scaffold software. The filtered spectra
counts were quantitated according to (Liu et al., 2004; Old et al., 2005) to derive the RSC, which is the log2
ratio of abundance between Samples 1 and 2. The RSC score was then used to calculate the ratio of
abundance between Samples 1 (siLuc) and 2 (siASM). Fold of protein abundance change between control
siLuc and siASM, as well as numbers of the peptides identified in each condition, are listed in the middle
and the ratio of abudundance change >2. The low confidence group are consisted of proteins each identified
by at least one unique peptides, and the ratio of abudance change >1.8.
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columns. The high confidence group are consisted of proteins each identified by at least two unique peptides,
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Accession,Number

High%Confidence,%number%of%unique%peptides%number%>2,%fold%of%change%>2.0,%from%siLuc/siASM%comparison
CD59,glycoprotein,,T,cell,activation
IPI00011302
Putative,uncharacterized,protein,ZNF326
IPI00337602,(+1)
VAMP3,,VesicleXassociated,membrane,protein,3
IPI00549343
VesicleXtrafficking,protein,SEC22b
IPI00006865
BetaX2Xmicroglobulin
IPI00004656,(+1)
Caveolin,,scaffolding,protein,within,caveolar,membranes
IPI00009236
5'Xnucleotidase,ecto,,CD73
IPI00009456
ATP,synthase,subunit,alpha,,mitochondrial
IPI00440493
RPN2,,subunit,of,NXoligosaccharyl,transferase,complex
IPI00028635,(+1)
VAMP7,,,vesicleXassociated,membrane,protein,7,,Isoform,1
IPI00020887
60,kDa,heat,shock,protein,,mitochondrial
IPI00784154
RasXrelated,protein,RabX7a
IPI00016342
Src family tyrosine kinase Yes
IPI00013981
SyntaxinX16,,Isoform,B
IPI00023149,(+1)
RPN1,,subunit,of,NXoligosaccharyl,transferase,complex
IPI00025874
GlypicanX4
IPI00232571
CD90,,possible,cellXcell,or,cellXligand,interaction,ThyX1,membrane,glycoprotein
IPI00022892,(+1)
Major,prion,protein,,Isoform,1
IPI00022284,(+4)
RasXrelated,protein,RabX1A,,isoform,1
IPI00005719,(+1)
GCP16,,palmitoyltransferase,,protein,palmitoylation
IPI00480022,(+1)
Putative,receptor,for,complement,component,1,Q,,mitochondrial
IPI00014230
Annexin,A2,,Isoform,2
IPI00418169,(+1)
TXcomplex,protein,1,subunit,beta
IPI00297779
Ragulator,complex,protein,LAMTOR1,,mTOR,regulation
IPI00016670
RasXrelated,protein,RXRas
IPI00020418
MyeloidXassociated,differentiation,marker
IPI00102685,(+1)
Serine/threonineXprotein,kinase,Nek2,,Isoform,1
IPI00021331
Cytochrome,c,oxidase,subunit,5A,,mitochondria,
IPI00025086
RasXrelated,protein,RalXB
IPI00004397
Erythrocyte,band,7,integral,membrane,protein
IPI00219682
RasXrelated,protein,RabX5C
IPI00016339
Proteolipid,protein,2,,function,unknown
IPI00030362
Protein,FAM3C
IPI00334282
SodiumXdependent,amino,acids,transporter
IPI00019472
Limbic,systemXassociated,membrane,protein
IPI00013303
SNAP23,,SynaptosomalXassociated,protein,23
IPI00010438
Pyruvate,kinase,PKM,,glycolysis
IPI00479186
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siLuc
#,peptides

siASM
#,peptides

44
71
37
28
19
63
14
13
12
10
8
7
7
7
7
20
18
12
6
6
6
16
5
5
5
5
20
5
5
18
4
4
4
4
4
4
4

siLuc/siASM
Fold of Change

0
1
0
0
0
4
0
0
0
0
0
0
0
0
0
2
2
1
0
0
0
2
0
0
0
0
3
0
0
3
0
0
0
0
0
0
0

36.2
32.1
30.6
23.4
16.2
12.2
12.2
11.4
10.6
9
7.4
6.6
6.6
6.6
6.6
6.5
5.9
5.9
5.8
5.8
5.8
5.3
5
5
5
5
5
5
5
4.5
4.2
4.2
4.2
4.2
4.2
4.2
4.2
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GTPase,IMAP,family,member,8
Cytochrome,bXc1,complex,subunit,Rieske,,mitochondrial
ATP,synthase,subunit,delta,,mitochondrial
91,kDa,protein
Heat,shock,cognate,71,kDa,protein,iIsoform,1
Peroxidasin,homolog,,isoform,1
Secretory,carrierXassociated,membrane,protein,1,,Isoform,1
Transmembrane,emp24,domainXcontaining,protein,10
TXcomplex,protein,1,subunit,eta
SynaptogyrinX2
StressX70,protein,,mitochondrial
RasXrelated,protein,RapX2b
RasXrelated,protein,RalXA
Protein,FAM162A
Protein,disulfideXisomerase,PDI,,protein,folding
MitogenXactivated,protein,kinase,scaffold,protein,1
ReticulonX3,,isoform,2
CD97,antigen,,Isoform,2,,potential,cell,adhesion,receptor
IFM3,,InterferonXinduced,transmembrane,protein,3
DeoxyribonucleaseX1Xlike,1
Cytochrome,c,oxidase,subunit,6B1
Cytochrome,c,oxidase,subunit,4,isoform,1,,mitochondrial
CofilinX1,,actin,cytoskeleton,regulation
CholineXphosphate,cytidylyltransferase,A
cDNA,FLJ59191,,highly,similar,to,NADH,dehydrogenase,(ubiquinone),1,alpha,subcomplex,subunit,13
TXcomplex,protein,1,subunit,theta,
SyntaxinX10,,isoform,1
Prohibitin
Transporter,for,monocarboxylate,,metabolism
Cell,sruface,receptor,,cellXmatrix,interaction
Ga(i)2,,isoform,1,,heterotrimeric,G,protein,subunit,,isoform,1
Collapsin,response,mediator,protein,4,long,variant
TXcomplex,protein,1,subunit,delta
StomatinXlike,protein,2
RasXrelated,protein,RabX2A
RasXrelated,protein,RabX14
Subunit,of,succinate,dehydrogenase,complex,,mitochondrial
Putative,chloride,channel,protein,7
Protein,disulfideXisomerase,A3
ProfilinX1
PeptidylXprolyl,cisXtrans,isomerase,A,,protein,folding
monocarboxylate,transporter,8
MHC,class,I,antigen
Lysosomal,acid,phosphatase

IPI00168482
IPI00026964
IPI00024920
IPI00871370,(+1)
IPI00003865
IPI00016112
IPI00005129
IPI00028055
IPI00018465,(+3)
IPI00013946,(+2)
IPI00007765
IPI00018364
IPI00217519
IPI00023001,(+1)
IPI00010796
IPI00030919
IPI00398795,(+3)
IPI00299412,(+4)
IPI00303726
IPI00026125,(+1)
IPI00216085,(+1)
IPI00006579
IPI00012011
IPI00329338,(+1)
IPI00942935
IPI00302925,(+1)
IPI00293402,(+1)
IPI00017334
IPI00024650
IPI00297160,(+19)
IPI00748145
IPI00029111
IPI00302927,(+2)
IPI00334190
IPI00031169
IPI00291928
IPI00965327
IPI00020524,(+2)
IPI00025252
IPI00216691
IPI00419585
IPI00000655
IPI00794678,(+2)
IPI00003807
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4
4
4
4
15
26
10
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
6
8
8
22
5
23
2
2
2
2
2
2
2
2
2
2
2
2

0
0
0
0
3
6
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2
2
7
1
8
0
0
0
0
0
0
0
0
0
0
0
0

4.2
4.2
4.2
4.2
3.8
3.8
3.5
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.2
2.8
2.8
2.8
2.8
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
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Src,familty,tyrosine,kinase,Fyn,,isoform,3
,VesicleXassociated,membrane,proteinXassociated,protein,B/C,,isoform,1
Uncharacterized,protein,C4orf52,,isoform,1
Solute,carrier,family,12,member,2,,isoform,1
RasXrelated,protein,RabX6A,,Isoform,1
Ovarian,carcinoma,immunoreactive,antigenXlike,protein
MitogenXactivated,proteinXbinding,proteinXinteracting,protein,iIsoform,1
GDNF,family,receptor,alphaX1,,isoform,1
Elongation,factor,1Xdelta,,isoform,1
Electron,transfer,flavoprotein,subunit,beta,,isoform,1
E3,ubiquitinXprotein,ligase,CHIP,,isoform,1
ApoptosisXinducing,factor,1,,Isoform,1,,mitochondrial
Integral,membrane,protein,2B,,amyloid,precursor,processing
HippocalcinXlike,protein,1,,calcium,binding,and,sensing
Ga(i)3,,G(k),subunit,alpha,,heterotrimeric,G,protein,subunit
Guanine,nucleotideXbinding,protein,G(I)/G(S)/G(O),subunit,gammaX12
MICOS,complex,subunit,MIC19,,mitochondrial
CD81,,TetraspaninX28,,cell,surface,protein
Calmodulin
CalciumXbinding,mitochondrial,carrier,protein,Aralar2
BXcell,receptorXassociated,protein,31
ATP,synthase,subunit,b,,mitochondrial
Src,family,tyrosine,kinase,Lyn,,isoform,B
Annexin,A1
Sortilin
Ephrin,typeXA,receptor,2,,receptor,tyrosine,kinase
Secretory,carrierXassociated,membrane,protein,3,,isoform,1

IPI00166845,(+2)
IPI00006211
IPI00397994,(+1)
IPI00022649,(+1)
IPI00023526,(+1)
IPI00555902
IPI00032409
IPI00008148,(+1)
IPI00023048,(+2)
IPI00004902,(+1)
IPI00025156,(+1)
IPI00000690,(+1)
IPI00031821
IPI00219344
IPI00220578
IPI00221232
IPI00015833,(+4)
IPI00000190,(+1)
IPI00075248,(+3)
IPI00007084,(+1)
IPI00218200,(+1)
IPI00029133
IPI:IPI00432416.4
IPI00218918
IPI00217882
IPI00021267
IPI00306382

2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
7
4
18

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
1
8

2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.5
2.3
2.1

Low Confidence, Number of unique peptides > 1, fold of change > 1.8, from siLuc/siASM comparison
SyntaxinX7,,isoform,1
IPI00289876,(+1)
Transmembrane,protein,C2orf18
IPI00550440,(+2)
DolichylXdiphosphooligosaccharideXXprotein,glycosyltransferase,48,kDa,subunit
IPI00297084
VXtype,proton,ATPase,subunit,d,1
IPI00034159
Translation,initiation,factor,eIFX2B,subunit,epsilon
IPI00011898,(+1)
ATP,synthase,subunit,gamma,,Isoform,liver,,mitochondrial
IPI00478410
Seprase,,isoform,1
IPI00295461,(+1)
Hormonally,upXregulated,neu,tumorXassociated,kinase
IPI00219553,(+1)
14X3X3,protein,gamma
IPI00220642
Vesicle,transport,through,interaction,with,tXSNAREs,homolog,1A
IPI00059472,(+1)
Vacuolar,protein,sortingXassociated,protein,45
IPI00090327
VXtype,proton,ATPase,subunit,B,,brain,isoform
IPI00007812
VXtype,proton,ATPase,116,kDa,subunit,a,isoform,2
IPI00000425
tumor,protein,D54,isoform,a
IPI00399265,(+4)
tropomyosin,alphaX3,chain,isoform,1
IPI00183968,(+7)

11
5
5
3
3
3
3
3
3
1
1
1
1
1
1

5
2
2
1
1
1
1
1
1
0
0
0
0
0
0

1.96
1.9
1.9
1.9
1.9
1.9
1.9
1.9
1.9
1.8
1.8
1.8
1.8
1.8
1.8
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Translocator,protein
TransgelinX2
TMEM181,protein,(Fragment)
TXcomplex,protein,1,subunit,zeta
TXcomplex,protein,1,subunit,gamma,isoform,b
Sodium/potassiumXtransporting,ATPase,subunit,betaX3
SideroflexinX1
Regulator,of,GXprotein,signaling,19
RasXrelated,protein,RapX1b
RasXrelated,protein,RabX11B
ProlactinXinducible,protein
PodocalyxinXlike,protein,1,precursor
PeptidylXprolyl,cisXtrans,isomerase,B
NADH,dehydrogenase,[ubiquinone],ironXsulfur,protein,8,,mitochondrial
NADH,dehydrogenase,[ubiquinone],flavoprotein,2,,mitochondrial
NADH,dehydrogenase,[ubiquinone],1,beta,subcomplex,subunit,10
NADH,dehydrogenase,[ubiquinone],1,alpha,subcomplex,subunit,5
Mitochondrial,import,inner,membrane,translocase,subunit,Tim23
Matrix,metalloproteinaseX14
Vesicle,transport,through,interaction,with,tXSNAREs,homolog,1B,,isoform,Long
Protein,SON,,isoform,F
Integrin,alphaX6,,isoform,AlphaX6X1X2B
Zinc,finger,protein,781,,isoform,1
VoltageXdependent,anionXselective,channel,protein,3,,isoform,1
Transmembrane,protein,87B,,isoform,1
Transmembrane,protein,55B,,isoform,1
TransX2,3XenoylXCoA,reductase,,isoform,1
TBC,domainXcontaining,protein,kinaseXlike,protein,,isoform,1
Secretory,carrierXassociated,membrane,protein,4,,isoform,1
Pyruvate,dehydrogenase,E1,component,subunit,beta,,isoform,1,,mitochondrial
Putative,adenosylhomocysteinase,2,,isoform,1
Phosphatidylinositol,4Xkinase,alpha,,isoform,1
Mitochondrial,Rho,GTPase,2,,isoform,1
ExportinX2,,isoform,1
ErlinX2,,isoform,1
CytoskeletonXassociated,protein,4,,isoform,1
Cell,cycle,control,protein,50A,,isoform,1
ATP,synthase,subunit,d,,,isoform,1,,mitochondrial
FAM73A,protein
Dystroglycan
Dihydrolipoyl,dehydrogenase,,mitochondrial
cytochrome,c,oxidase,subunit,VIIa,polypeptide,2,(liver),precursor
Cytochrome,c,oxidase,subunit,6C
Cytochrome,c,oxidase,subunit,5B,,mitochondrial

IPI00026850
IPI00550363,(+1)
IPI00166790,(+1)
IPI00027626
IPI00290770,(+3)
IPI00008167
IPI00009368
IPI00028108
IPI00015148
IPI00020436
IPI00022974
IPI00299116,(+2)
IPI00646304
IPI00010845
IPI00291328,(+2)
IPI00479905
IPI00554681
IPI00007309,(+5)
IPI00218398,(+1)
IPI00063784
IPI00000192,(+3)
IPI00010697,(+6)
IPI00853563
IPI00031804,(+1)
IPI00783380,(+1)
IPI00030530,(+1)
IPI00100656
IPI00291665
IPI00056310,(+2)
IPI00003925,(+2)
IPI00182938,(+2)
IPI00070943
IPI00465059
IPI00022744,(+1)
IPI00026942
IPI00141318,(+1)
IPI00019381,(+2)
IPI00220487
IPI00168047
IPI00028911
IPI00015911
IPI00026570,(+1)
IPI00015972
IPI00021785
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1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
1.8
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IPI00017510
IPI00003635,(+1)
IPI00021807,(+2)
IPI00792011,(+1)
IPI00007611
IPI00022891
IPI00294501

1
1
1
1
1
1
1

0
0
0
0
0
0
0

1.8
1.8
1.8
1.8
1.8
1.8
1.8
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Cytochrome,c,oxidase,subunit,2
cDNA,FLJ56280,,highly,similar,to,Endoplasmic,reticulumXGolgi,intermediate,compartment,protein,1
cDNA,FLJ56157,,highly,similar,to,Glucosylceramidase
Calcyphosin
ATP,synthase,subunit,O,,mitochondrial
ADP/ATP,translocase,1
7Xdehydrocholesterol,reductase
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Table S2. The spectral counting data for the protein hits that are increased in the DRM
association following ASM siRNA treatment.
Experiments, data analyses and quantitation were conducted similar as in the legends of
Supplementary Table 1. Shown are the proteins which show abundance change greater than >2fold between the sample 2 (siASM) and Samples 1 (siLuc). Fold of protein abundance change
between siASM and control siLuc, as well as numbers of the peptides identified in each condition,

Biology Open • Supplementary information

are listed in the middle columns.
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Bio	
  View:Identified	
  Proteins	
  (878)

Accession	
  Number

siLuc
#	
  peptides

siASM
#	
  peptides

siASM/siLuc
Fold	
  of	
  Change

1
1
1
0
0
0
0
0
0
0
2
0
0
0
0
0
2
0
0
2
2
0
3
0
2
0
0
0
0
0
0
0
7
1
1
1
0

101
86
61
27
24
21
19
17
14
12
31
11
11
10
10
9
25
8
7
18
18
6
22
5
15
5
5
5
5
5
5
5
38
9
9
9
4

45.4
38.8
27.7
22.6
20.2
17.8
16.2
14.6
12.2
10.6
9.9
9.8
9.8
9
9
8.2
8.1
7.4
6.6
5.9
5.9
5.8
5.5
5
5
5
5
5
5
5
5
5
4.8
4.6
4.6
4.6
4.2

Myoferlin,	
  isoform	
  1
Flotillin-‐1
Flotillin-‐2
Alpha-‐enolase,	
  isoform	
  alpha
Moesin
Reticulon-‐4,	
  isoform	
  2
Golgi	
  apparatus	
  protein	
  1,isoform	
  2
Mitochondrial	
  inner	
  membrane	
  protein,	
  isoform	
  2
Inositol	
  1,4,5-‐trisphosphate	
  receptor	
  type	
  3
Vesicle-‐fusing	
  ATPase
Cytochrome	
  b-‐c1	
  complex	
  subunit	
  1,	
  mitochondrial
NADH	
  dehydrogenase	
  [ubiquinone]	
  iron-‐sulfur	
  protein	
  2,	
  mitochondrial
Apolipoprotein	
  B-‐100
Trifunctional	
  enzyme	
  subunit	
  beta,	
  mitochondrial
Cathepsin	
  D
Heat	
  shock	
  protein	
  HSP	
  90-‐beta
Cytochrome	
  b-‐c1	
  complex	
  subunit	
  2,	
  mitochondrial
Metalloreductase	
  STEAP3,	
  isoform	
  1
Cation-‐dependent	
  mannose-‐6-‐phosphate	
  receptor
Phosphoglycerate	
  kinase	
  1
V-‐type	
  proton	
  ATPase	
  116	
  kDa	
  subunit	
  a	
  isoform	
  1,	
  isoform	
  2
DNA-‐dependent	
  protein	
  kinase	
  catalytic	
  subunit,	
  isoform	
  1
Carboxypeptidase	
  D
Vimentin
Very	
  low-‐density	
  lipoprotein	
  receptor,	
  isoform	
  Long
Integrin	
  beta-‐4,	
  Isoform	
  Beta-‐4C
Integrin	
  beta-‐3,	
  Isoform	
  Beta-‐3A
Calcium-‐transporting	
  ATPase	
  type	
  2C	
  member	
  1,	
  isoform	
  2
Surfeit	
  locus	
  protein	
  4,	
  isoform	
  1
Plexin-‐D1,	
  isoform	
  1
Epoxide	
  hydrolase	
  1
Collagen	
  alpha-‐3(V)	
  chain
Conserved	
  hypothetical	
  protein
Neuroblast	
  differentiation-‐associated	
  protein	
  AHNAK
LAMP-‐2A	
  of	
  Lysosome-‐associated	
  membrane	
  glycoprotein	
  2
Endoplasmin
Sulfide:quinone	
  oxidoreductase,	
  mitochondrial

IPI00021048	
  (+1)
IPI00027438
IPI00789008
IPI00465248
IPI00219365	
  (+1)
IPI00298289
IPI00414717	
  (+2)
IPI00554469
IPI00291607
IPI00006451	
  (+1)
IPI00013847
IPI00025239	
  (+1)
IPI00022229
IPI00022793
IPI00011229
IPI00414676
IPI00305383
IPI00019350	
  (+3)
IPI00025049
IPI00169383
IPI00743576	
  (+2)
IPI00296337
IPI00027078
IPI00418471
IPI00024273	
  (+2)
IPI00027422	
  (+3)
IPI00303283
IPI00220473	
  (+8)
IPI00005737	
  (+2)
IPI00412492	
  (+1)
IPI00009896
IPI00018279
IPI00916096
IPI00021812
IPI00009030	
  (+2)
IPI00027230
IPI00009634
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High	
  Confidence,	
  number	
  of	
  unique	
  peptides	
  number	
  >2,	
  fold	
  of	
  change	
  >2.0,	
  from	
  siASM/siLuc	
  comparison

Protein	
  disulfide-‐isomerase	
  A4
Desmoglein-‐4,	
  isoform	
  2
Tenascin,	
  isoform	
  1
Leucyl-‐cystinyl	
  aminopeptidase,	
  isoform	
  1
Heterogeneous	
  nuclear	
  ribonucleoprotein	
  M,	
  isoform	
  1
Gelsolin,	
  isoform	
  1
High	
  affinity	
  cationic	
  amino	
  acid	
  transporter	
  1
Ceruloplasmin
Calpain-‐1	
  catalytic	
  subunit
A-‐kinase	
  anchor	
  protein	
  6
Niemann-‐Pick	
  C1	
  protein
Translational	
  activator	
  GCN1
signal-‐regulatory	
  protein	
  alpha	
  precursor
Serotransferrin
Prostaglandin	
  F2	
  receptor	
  negative	
  regulator
Prolow-‐density	
  lipoprotein	
  receptor-‐related	
  protein	
  1
NudC	
  domain-‐containing	
  protein	
  2
TGN51	
  of	
  Trans-‐Golgi	
  network	
  integral	
  membrane	
  protein	
  2
Gnas-‐2	
  of	
  Guanine	
  nucleotide-‐binding	
  protein	
  G(s)	
  subuni,	
  	
  alpha	
  isoforms	
  short
Perilipin-‐3,	
  isoform	
  B
Adenylate	
  kinase	
  domain-‐containing	
  protein	
  1,	
  isoform	
  6
Protein	
  disulfide-‐isomerase	
  A6,	
  isoform	
  2
Sodium/potassium-‐transporting	
  ATPase	
  subunit	
  beta-‐1,	
  isoform	
  1
Heparan	
  sulfate	
  2-‐O-‐sulfotransferase	
  1,	
  isoform	
  1
Choline	
  transporter-‐like	
  protein	
  2,	
  isoform	
  1
CD276	
  antigen,	
  isoform	
  1
Catenin	
  beta-‐1,	
  isoform	
  1
Calcium-‐binding	
  mitochondrial	
  carrier	
  protein	
  SCaMC-‐1,	
  isoform	
  1
Integrin	
  alpha-‐2
HCG1990625,	
  isoform	
  CRA_a
cDNA	
  FLJ56903,	
  highly	
  similar	
  to	
  Tubulin	
  beta-‐7	
  chain
cDNA	
  FLJ56389,	
  highly	
  similar	
  to	
  Elongation	
  factor	
  1-‐gamma
cDNA	
  FLJ55574,	
  highly	
  similar	
  to	
  Calnexin
Transferrin	
  receptor	
  protein	
  1
NADH-‐ubiquinone	
  oxidoreductase	
  75	
  kDa	
  subunit
C-‐type	
  mannose	
  receptor	
  2
Transmembrane	
  protein	
  87A,	
  isoform	
  1
Voltage-‐dependent	
  anion-‐selective	
  channel	
  protein	
  2,	
  isoform	
  2
DnaJ	
  homolog	
  subfamily	
  C	
  member	
  13
Protein	
  S100-‐A9
proteasome-‐associated	
  protein	
  ECM29	
  homolog
N-‐acetylglucosamine-‐6-‐sulfatase
Leucine-‐rich	
  PPR	
  motif-‐containing	
  protein,	
  mitochondrial
Neurofascin,	
  Isoform	
  7

IPI00009904
IPI00428691	
  (+1)
IPI00031008	
  (+6)
IPI00307017	
  (+1)
IPI00171903	
  (+1)
IPI00026314	
  (+2)
IPI00027728
IPI00017601	
  (+1)
IPI00011285
IPI00297089
IPI00005107
IPI00001159
IPI00332887	
  (+1)
IPI00022463
IPI00022048
IPI00020557
IPI00103142
IPI00012545	
  (+4)
IPI00219835	
  (+1)
IPI00303882
IPI00552962	
  (+1)
IPI00299571	
  (+1)
IPI00747849	
  (+1)
IPI00549891
IPI00549521
IPI00410488	
  (+3)
IPI00017292	
  (+1)
IPI00337494
IPI00013744
IPI00969623
IPI00909140
IPI00000875	
  (+1)
IPI00020984	
  (+1)
IPI00022462
IPI00604664	
  (+1)
IPI00005707
IPI00783698	
  (+1)
IPI00024145	
  (+4)
IPI00307259
IPI00027462	
  (+1)
IPI00157790
IPI00012102	
  (+1)
IPI00783271
IPI00384998	
  (+11)
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0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
21
1
1
3
2
1
0
0
0
0
0

4
4
4
4
4
4
4
4
4
4
8
7
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
30
73
6
6
11
8
5
2
2
2
2
2

4.2
4.2
4.2
4.2
4.2
4.2
4.2
4.2
4.2
4.2
4.1
3.7
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.4
3.3
3.2
3.2
2.9
2.8
2.8
2.6
2.6
2.6
2.6
2.6
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nhibitor	
  of	
  nuclear	
  factor	
  kappa-‐B	
  kinase-‐interacting	
  protein,	
  isoform	
  4
Inositol	
  1,4,5-‐trisphosphate	
  receptor	
  type	
  1,	
  isoform	
  3
Semaphorin-‐4B,	
  isoform	
  2
Multidrug	
  resistance-‐associated	
  protein	
  1,	
  isoform	
  2
Dynein	
  heavy	
  chain	
  2,	
  axonemal,	
  isoform	
  2
Titin,	
  isoform
Putative	
  SMEK	
  homolog	
  3,	
  isoform	
  1
Nicastrin,	
  isoform	
  1
NADH	
  dehydrogenase	
  [ubiquinone]	
  flavoprotein	
  1,	
  mitochondrial,	
  isoform	
  1
Kinectin,	
  isoform	
  1
Glial	
  fibrillary	
  acidic	
  protein,	
  isoform	
  1
Epidermal	
  growth	
  factor	
  receptor,	
  isoform	
  1
Inositol	
  monophosphatase	
  3
HLA	
  class	
  I	
  histocompatibility	
  antigen,	
  alpha	
  chain	
  G
Histone	
  H3.2
Fatty	
  acid-‐binding	
  protein,	
  epidermal
Ezrin
Dynein	
  heavy	
  chain	
  domain-‐containing	
  protein	
  1
cDNA	
  FLJ60299,	
  highly	
  similar	
  to	
  Rab	
  GDP	
  dissociation	
  inhibitor	
  beta
Alpha-‐mannosidase	
  2
60S	
  ribosomal	
  protein	
  L4
Transmembrane	
  9	
  superfamily	
  member	
  4
NADPH-‐-‐cytochrome	
  P450	
  reductase
NADH-‐cytochrome	
  b5	
  reductase	
  1
Neuroplastin,	
  isoform	
  1
CD166	
  antigen,	
  isoform	
  1
Acylglycerol	
  kinase,	
  isoform	
  1,	
  mitochondrial
cDNA	
  FLJ52398,	
  highly	
  similar	
  to	
  Cadherin-‐13
Voltage-‐dependent	
  anion-‐selective	
  channel	
  protein	
  1
Trifunctional	
  enzyme	
  subunit	
  alpha,	
  mitochondrial
Monocarboxylate	
  transporter	
  4
Inner	
  centromere	
  protein,	
  isoform	
  2
51	
  kDa	
  protein
HLA	
  class	
  I	
  histocompatibility	
  antigen,	
  A-‐2	
  alpha	
  chain
Lysosome	
  membrane	
  protein	
  2

IPI00043598
IPI00218659	
  (+4)
IPI00513964
IPI00008338	
  (+6)
IPI00651691	
  (+1)
IPI00759754	
  (+4)
IPI00900377
IPI00021983	
  (+1)
IPI00028520	
  (+1)
IPI00328753
IPI00025363	
  (+2)
IPI00018274
IPI00787853
IPI00015988	
  (+3)
IPI00171611	
  (+6)
IPI00007797
IPI00843975	
  (+1)
IPI00936051
IPI00031461	
  (+1)
IPI00003802
IPI00003918
IPI00021985	
  (+1)
IPI00470467	
  (+3)
IPI00470674
IPI00011578	
  (+4)
IPI00015102	
  (+3)
IPI00019353	
  (+1)
IPI00024046
IPI00216308
IPI00031522
IPI00006666
IPI00759472	
  (+1)
IPI00328883	
  (+8)
IPI00876963	
  (+3)
IPI00217766
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0
0
0
0
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
1
1
1
1
1
1
8
2
2
2
2
10
6

2
2
2
2
15
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
7
4
4
4
4
4
4
20
6
6
6
6
23
14

2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.5
2.3
2.3
2.3
2.3
2.3
2.3
2.3
2.2
2.2
2.2
2.2
2.2
2.1
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Table S3. List of proteins identified in ASM-sensitive DRM proteome that are also known to
be palmitoylated proteins.
Hits listed in supplementary Table 1 were cross-referenced to the palmitoyl-proteome database
(SwissPalm) (Blanc et al., 2015), 65 proteins are found to be known as palmitoylated protein and
listed here. Semi-quantitative mass-spectrometry data, including the fold of protein abundance
change between cells treated with Luciferase siRNA (siLuc) and ASM siRNA (siASM), as well as
the numbers of the peptides identified in each condition for each protein, are shown in the middle
columns. The numbers of articles that reported the particular protein found in the palmitoylproteomes is indicated in the second to the last column. Both UniProt accession number and IPI
Biology Open • Supplementary information

accession numbers are listed. Proteins are grouped according to their functional categories.
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UniProt
Protein,,name Protein,Functions,or,Biological,Process
accession,number

siLuc
peptides

siASM
peptides

#,of,,articles
palmitoy9proteome,studies

0

3*of*15

IPI00011302

0

2*of*15

IPI00009456

5.9
5.8
4.2
3.4
2.8
2.6
2.3

44
14
18
6
4
3
22
2
4

2
0
0
0
7
0
1

2*of*15
6*of*15
10*of*15
1*of*15
8*of*15
8*of*15
1*of*15

IPI00022892*(+1)
IPI00014230
IPI00019472
IPI00299412*(+4)
IPI00297160*(+19)
IPI00000190*(+1)
IPI00021267

6.6
5
5
3.4
3.4

7
5
5
3
3

0
0
0
0
0

6*of*15
5**of*15
9*of*15
6*of*15
6*of*10

IPI00013981
IPI00004397
IPI00020418
IPI00217519
IPI00018364

Fold
of change

IPI,database
Accession,Number

Receptors,%Cell%surface%proteins%or%transporters:%
P13987
CD59
CD59*glycoprotein,*T*cell*activation
P21589
NT5E
5'Dnucleotidase*ecto,*CD73
P04216
THY1
CD90,*possible*cellDcell*or*cellDligand*interaction
Q07021
C1QBP
Putative*receptor*for*complement*component*1*Q
Q15758
SLC1A5
SodiumDdependent*amino*acids*transporter
P48960
CD97
CD97*antigen,*isoform*2,*potential*cell*adhesion*receptor
P16070
CD44
CD44,*Cell*sruface*receptor,*cellDmatrix*interaction
P60033
CD81
CD81,*TetraspaninD28,*cell*surface*protein
P29317
EPHA2,*ECK
Ephrin*typeDA*receptor*2,*receptor*tyrosine*kinase
GTPases;%Other%Signaling%Proteins:%
P07947
YES
Src family tyrosine kinase Yes
P11234
RALB
RasDrelated*protein*RalDB
P10301
RRAS
RasDrelated*protein*RDRas
P11233
RALA
RasDrelated*protein*RalDA
P61226
Rap2b
RasDrelated*protein*RapD2b
P04899
GNAI2
Ga(i)2,*isoform*1,*heterotrimeric*G*protein*subunit
P06241
FYN
Src*familty*tyrosine*kinase*Fyn,*isoform*3
P08754
GNAI3
Ga(i)3,*G(k)*subunit*alpha,*heterotrimeric*G*protein*subunit
P07948
LYN
Src*family*tyrosine*kinase*Lyn,*isoform*B
Vesicular%Trafficking:%
Q15836
VAMP3
O75396
SEC22B
P51809
VAMP7
P51149
RAB7
O14662
STX16
P62820
RAB1A
P07355
ANXA2
O00161
SNAP23
P51148
RAB5C
O15126
SCAMP1
P49755
TMP21
O43760
SYNGR2
O60499
STX10

VAMP3,*VesicleDassociated*membrane*protein*3
VesicleDtrafficking*protein*Sec22B
VAMP7,*VesicleDassociated*membrane*protein*7,*isoform*1
RasDrelated*protein*RabD7a
SyntaxinD16,*Isoform*B
RasDrelated*protein*RabD1A,*isoform*1
Annexin*A2,*calcium/phospholipidDbinding*protein
SNAP23,*SynaptosomalDassociated*protein*23
RasDrelated*protein*RabD*5C
Secretory*carrierDassociated*membrane*protein*1
Transmembrane*protein*Tmp21
SynaptogyrinD2
Syntaxin*10

36.2
12.2

2.8

5

1

11*of*15

IPI00748145

2.6
2.6

2
2

0
0

6*of*15
11*of*15

IPI00166845*(+2)
IPI00220578

2.6

2

0

3 of 15

IPI00432416*(+4)

30.6
23.4
9
6.6

37
28
10
7

0
0
0
0

11*of*15
3*of*15
8*of*15
4*of*15

IPI00549343
IPI00006865
IPI00020887
IPI00016342

6.6

7

0

1*of*15

5.8
5.8
4.2
4.2

6
6
4
4

0
0
0
0

5*of*15
6*of*15
13*of*15
7*of*15

3.5

10

2

9*of*15

IPI00005129

3.4
3.4
3.2

3
3
6

0
0
1

3*of*15
2*of*15
6*of*15

IPI00028055
IPI00013946*(+2)
IPI00293402*(+1)
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IPI00023149*(+1)

IPI00005719*(+1)
IPI00418169*(+1)
IPI00010438
IPI00016339
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High%Confidence,%number%of%unique%peptides%number%>2,%fold%of%change%>2.0

P61106
O95292
P20340
P61019
Q99523
P04083
O15400

RAB14
VAPB
RAB6A
RAB2A
SORT1
ANXA1
STX7

RasDrelated*protein*RabD14
VesicleDassociated*membrane*proteinDassociated*protein*B/C
RasDrelated*protein*RabD*6A
RasDrelated*protein*RabD2A
Sortillin,*as*sorting*receptor*on*Golgi*compartment
Annexin*A1,*calcium/phospholipidDbinding*protein
SyntaxinD7,*isoform*1

2.6
2.6
2.6
2.6
2.5

2
2
2
2
7

0
0
0
0
2

5*of*15
2*of*15
2*of*15
4*of*15
5*of*15

IPI00291928
IPI00006211
IPI00023526*(+1)
IPI00031169
IPI00217882

2.6
2

2
11

0
5

4*of*15
7*of*15

IPI00218918
IPI00289876*(+1)

Erythrocyte*band*7*integral*membrane*protein
CofilinD1,*actin*cytoskeleton*regulation
InterferonDinduced*transmembrane*protein*3
ProfilinD1,*actin*cytoskeleton*regulation

4.5
3.4
3.4
2.6

18
3
3
2

3
0
0
0

10*of*15
5*of*15
7*of*15
5*of*15

IPI00219682
IPI00012011
IPI00303726
IPI00216691

Scaffolding%Proteins%and%Protein%Folding:%
Q03135
CAV1
Caveolin,*scaffolding*protein*within*caveolar*membranes
P07237
PDIA1
Protein*disulfideDisomerase*PDI,*protein*folding
P50990
CCT8
TDcomplex*protein*1*subunit*theta*
P50991
CCT4
TDcomplex*protein*1*subunit*delta
P62937
PPIA
PeptidylDprolyl*cisDtrans*isomerase*A,*protein*folding
P30101
PDIA3
Protein*disulfideDisomerase*A3
Q9Y287
ITM2B
Integral*membrane*protein*2B,*amyloid*precursor*processing

12.2
3.4
3.4
2.6
2.6
2.6
2.6

63
3
3
2
2
2
2

4
0
0
0
0
0
0

4*of*15
4*of*15
5*of*15
4*of*15
7*of*15
3*of*15
7*of*15

IPI00009236
IPI00010796
IPI00302925*(+1)
IPI00302927*(+2)
IPI00419585
IPI00025252
IPI00031821

Metabolism:%
P04844
P04843
P20674
P14618
P47985
P53985
P31040
Q9NX63

RPN2
RPN1
COX5A
PKM
UQCRFS1
SLC16A1
SDHA
CHCHD3

RPN2,*Subunit*of*NDoligosaccharyl*transferase*complex
RPN1,*Subunit*of*NDoligosaccharyl*transferase*complex
Cytochrome*c*oxidase*subunit*5A,*mitochondria*
Pyruvate*kinase*PKM,*glycolysis
Cytochrome*bDc1*complex*subunit*11,*mitochondrial
Transporter*for*monocarboxylate,*metabolism
Subunit*of*Succinate*dehydrogenase*complex,*mitochondrial
MICOS*complex*subunit*MIC19,*mitochondrial

10.6
6.6
5
4.2
4.2
2.8
2.6
2.6

12
7
5
4
4
8
2
2

0
0
0
0
0
2
0
0

4*of*15
3*of*15
2*of*15
6*of*15
3*of*15
2*of*15
3*of*15
5*of*15

IPI00028635*(+1)
IPI00025874
IPI00025086
IPI00479186
IPI00026964
IPI00024650
IPI00965327
IPI00015833*(+4)

Others
Q7Z5G4
Q6IAA8
Q96S97
Q04941
Q96A26
O95831
P37235
Q56VL3

GOLGA7
LAMTOR1
MYADM
PLP2,*A4
FAM162A
AIFM1
HPCAL1
OCIAD2

GCP16,*palmitoyltransferase,*protein*palmitoylation
Ragulator*complex*protein*LAMTOR1,*mTOR*regulation
MyeloidDassociated*differentiation*marker
Proteolipid*protein*2,*function*unknown
Protein*FAM162A
ApoptosisDinducing*factor*1,*Isoform*1,*mitochondrial
HippocalcinDlike*protein*1,*calcium*binding*and*sensing
Ovarian*carcinoma*immunoreactive*antigenDlike*protein

5.8
5
5

6
5
5

0
0
0

9*of*15
11*of*15
5*of*15

IPI00480022*(+1)
IPI00016670
IPI00102685*(+1)

4.2
3.4
2.6

4
3
2
2
2

0
0
0

5*of*15
5*of*15
2*of*15

IPI00030362
IPI00023001*(+1)
IPI00000690*(+1)

0

2*of*15

IPI00219344

0

1*of*15

IPI00555902

Cytoskeletal%Proteins:%
P27105
BND7
P23528
CFL1
Q01628
IFM3
P07737
PFN1

2.6

2.6
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